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A diagnosis of cancer and its subsequent treatment can have a significant impact on 
an person’s mental wellbeing. The way patients perceive and cope with their illness can help 
to understand emotional distress. Using the Self -Regulation Model of Common Sense Illness 
Representations (SRM) as a theoretical framework, this thesis aimed to 1) examine the ability 
of illness perceptions and coping to predict psychological distress in non-muscle invasive 
bladder cancer (NMIBC) patients’ on surveillance and 2) achieve insight into the lived 
experiences of NMIBC. A mixed-methods research design was utilised which assessed illness 
perceptions, coping and psychological distress in (N = 84) participants. Semi-structured 
interviews were carried out with a subset (N = 10) of the sample. All interviews were 
recorded and transcribed verbatim. Hierarchical regression analyses revealed that illness 
perceptions and avoidant coping predicted 20.5% of the variance in depression and 54.7% in 
anxiety. Stronger perceptions of Timeline, Emotional Representations and avoidant coping 
were found to be the key predictors of emotional distress. Interview data were analysed using 
Interpretative Phenomenological Analysis (IPA) which generated three super-ordinate 
themes. These comprised of: Making Sense of NMIBC, The Dynamic Nature of Illness 
Perceptions and Coping. This is the first study to date that utilised the SRM to examine 
illness perceptions, coping and psychological distress in NMIBC patients on surveillance, and 
the first to include a qualitative component to examine the full SRM in the context of 
NMIBC. The quantitative and qualitative findings are integrated and presented in the context 
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Chapter 1: Introduction 
1.1: Overview of Present Study  
This study aimed to explore illness perceptions, coping and psychological distress in 
patients with non-muscle invasive bladder cancer (NMIBC) on surveillance, using a mixed 
methods approach. Within the literature, a number of studies have explored the impact of 
bladder cancer (BC) on patients physical health and social functioning. However, there is a 
lack of literature pertaining to patients’ illness perceptions, coping and emotional wellbeing, 
particularly in the context of NMIBC. This is despite the fact that patients with NMIBC, who 
have received medical treatment, face the possibility of remaining on surveillance for many 
years due to the high recurrence rates of tumours. Furthermore, burgeoning research has 
indicated that NMIBC patients may be at increased risk of experiencing psychological 
distress. In order to effectively address the research questions, this study was embedded in an 
empirically supported psychological theoretical model; The Self-Regulation Model of 
Common Sense Illness Representations (SRM). 
This thesis sought to address the gaps in the literature and was the first study to 
include both quantitative and qualitative elements to examine the full SRM in the context of 
NMIBC. Therefore, the quantitative research question was: ‘To what extent do illness 
perceptions and coping strategies explain psychological distress in patients with NMIBC?’.  
There is a lack of focus in the literature regarding the individual lived experiences of NMIBC 
patients. Therefore, their stories needed to be told, in their own words, in order to understand 
their perspectives. The qualitative research question was as follows: ‘How do patients with 
NMIBC experience their illness in terms of their illness perceptions, coping strategies and 
psychological wellbeing?’.  
It was hoped that the aims of the study adequately answered the research questions 
and made an original contribution to the literature. With this in mind, an overview of the 
layout of the thesis is presented. 
 
1.2: Thesis Structure  
 A critical review of the disseminated literature in relation to BC, illness perceptions, 
coping and psychological distress are outlined in chapter two. Chapter three illustrated the 
quantitative and qualitative methodology and research design of this study as well as a 
description of the participants, data collection and analysis. The quantitative and qualitative 
findings are presented in chapter four. Finally, chapter five discussed the findings in the 
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context of the broader literature. Methodological considerations, implications for future 
research and clinical practice are outlined. 
 
1.2.1: Chapter Two: Literature Review  
 The existing literature pertaining to BC, psycho-social outcomes for BC patients and 
the illness perceptions literature are reviewed and synthesised. Gaps in the literature are 
identified. Finally, current study aims, hypothesis and research questions are presented.  
 
1.2.2: Chapter Three: Methodology  
 The rationale supporting the mixed methods approach and methodological design are 
discussed. The process of participant recruitment, data collection and analysis are outlined. 
Finally, ethical issues are addressed.  
 
1.2.3: Chapter Four: Results  
A detailed summary of the quantitative findings are presented. Regarding the 
qualitative component, synthesised findings from ten transcribed participant interviews into 
three superordinate themes are illustrated. Themes are discussed in the context of direct 
quotes and interpretive comments.  
 
1.2.4: Chapter Five: Discussion  
 A summary and critical discussion of the quantitative and qualitative findings in the 
context of the current literature are delineated. Quantitative and qualitative findings are 
integrated. A discussion about the methodological consideration of the current study as well 
as implications for future research and clinical practice are considered. The chapter 










Chapter 2: Literature Review 
2.1: Literature Search Strategy 
 Relevant research articles were identified through a complete search of a number of 
databases including: Google Scholar, PsychInfo, PsychArticles, Cochrane Database and Web 
of Science as well as the Theses database via the Glucksman Library in University of 
Limerick. A comprehensive list of key search words and terms (and their variants) were 
generated and comprised of the following: Self-Regulation Model and its associated terms 
(common sense model, illness perceptions, illness representations, illness cognitions, beliefs); 
Bladder Cancer (and BC, NMIBC, MIBC, cancer, illness, physical health, health); 
Psychological Distress (and adjustment, anxiety, depression, disorder, psychological health, 
well-being, mental health, mental illness, outcomes); elderly (and old, age, adult); and Lived 
Experiences (and qualitative, IPA, subjective experiences). Following this, relevant articles 
were appraised and saved for critique. Finally, the reference sections of key articles were 
examined for suitable empirical research. 
 
2.2: Bladder Cancer  
2.2.1: The Bladder 
The bladder is an organ, in the urinary tract, located at the base of the pelvis. The 
urinary tract comprises of the kidneys, ureters, the urethra and the bladder. The ureters 
transport urine to the bladder where it accumulates and it exits through the urethra (Anderson, 
2018a). The bladder is comprised of a number of layers; the urothelium, the peritoneum, the 
lamina propria, mucosa, superficial muscle, deep muscle, and peri-vesical tissue (Brooker & 
Nicol, 2011). 
2.2.2: Bladder Cancer 
Cancer refers to the growth of abnormal cells in the body. These cells can form a 
malignant ‘cancerous’ growth or tumour. Bladder cancer (BC) occurs when abnormal cells 
grow in the inner lining of the bladder, typically beginning in the urothelium (Brooker & 
Nicol, 2011). BC is a urological cancer. There are two main stages of BC; non-muscle 
invasive bladder cancer (NMIBC) and muscle invasive bladder cancer (MIBC). For 
reference, the stages of BC are delineated in Appendix I.  
BC is classified according to the stage of the tumour. BC is demarcated by the extent 
to which the tumour has invaded the wall of the bladder. Stage Ta, Tis and T1 are classified 
as NMIBC while Stages T2 to T4 are classified as MIBC (Anderson, 2018a). The key 
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distinguishing feature between NMIBC and MIBC is that non-muscle invasive tumours have 
not grown into the muscular wall while muscle-invasive tumours have entered the muscle 
layers. 
 
2.2.3: Epidemiology of BC 
BC is among the most prevalent cancers internationally. It is the tenth most common 
type of cancer globally (Bray et al., 2018). Bray and colleagues (2018) reported 
internationally over 540,000 new cases of BC, and 195,000 deaths, annually. The National 
Cancer Registry Ireland (2020) most recent statistics, from the year 2015, reported that BC 
accounted for just under ten per cent of cancer diagnoses in Ireland. It is three to four times 
more prevalent among men than women (Chang et al., 2016). The incidence rate increases 
with advancing age with most cases being diagnosed after the age of sixty (Anderson, 
2018b). Seventy five to eighty per cent of new cases of BC are diagnosed as NMIBC while 
the remainder are diagnosed as MIBC (Burger et al., 2013; Gallagher & Milowsky, 2009). 
 
2.2.4: Risk Factors 
There are a number of well researched risk factors that are proven to be associated 
with the development of BC. Age and gender are related to BC, as previously outlined. The 
most well established risk factor is smoking. Tobacco smoking, including a history of 
smoking, is associated with around 50% of diagnoses (Cumberbatch & Noon, 2019). 
Occupational exposures are also significantly associated with increased risk. Research has 
demonstrated that working with industrial products such as chemical and electrical 
processing increases the risk of BC (Sanli et al., 2017). It has been reported that occupational 
exposure accounts for approximately 20% of BC incidents (Anderson, 2018a). While 
smoking and occupational exposures are the most proven risk factors, a number of other 
factors have been investigated. For example, some studies have reported an association 
between family history and genetics with an increased risk of BC, however the evidence is 
currently unclear (Witjes et al., 2017). A number of other factors have been associated with a 
slightly elevated risk including reduced fruit and vegetable consumption, low water drinking 
and alcohol use, although these have not been definitively proven (Cumberbatch & Noon, 
2019).  
 
2.2.5: Presentation, Diagnosis, Treatment and Recurrence of NMIBC 
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The most frequent symptoms of BC are well documented in the literature. Painless 
haematuria (blood in the urine) is the most common presenting complaint (Chang et al., 
2016). Chang and colleagues (2016) described other, less common, symptoms of BC 
including increased frequency and need to pass urine, in the absence of a urinary tract 
infection. Additionally, pelvic pain can be seen, particularly in more advanced cases 
(Anderson, 2018a). 
Diagnosis of BC requires a number of steps, the first of which is a physical 
examination. Patients then typically undergo a cystoscopy procedure, which is an endoscopic 
procedure where a flexible scope is inserted into the bladder in order to examine the cells 
under a local or general anaesthetic (Sanli et al., 2017). During this procedure, imaging of the 
urinary tract (e.g., an ultrasound) can be carried out (Cumberbatch & Noon, 2019). Diagnosis 
can be confirmed by taking a biopsy of the cells (Witjes et al., 2017). The tumour is staged 
and graded. The grading of the tumour is more significant in determining prognosis than the 
stage of the cancer. Tumours are classified as either low, medium or high grade with low 
grade being the least aggressive (Sanli et al., 2017). For example, Stage T1 tumours are 
considered low grade (Anastasiadis & de Reijke, 2012). The stage Tis (CIS) is a NMIBC 
tumour. However, it is classified as a high grade carcinoma and it is likely to advance to 
MIBC without treatment (Anastasiadis & de Reijke, 2012). 
Treatment of NMIBC comprises of a resection of the tumour(s), known as 
transurethral resection of bladder tumours (TURBT) (Witjes et al., 2017). This is a surgical 
procedure with the patient under general anaesthetic, whereby the tumour is removed from 
the bladder, keeping the bladder intact. Following TURBT, patients are typically placed on 
“surveillance”, that is where they undergo routine cystoscopies every three months for the 
first three years, six monthlies for two years and then yearly for life. If the tumour recurs, 
they return to more frequent surveillance cystoscopies. Depending on the grade of the 
tumour, patients may also undergo adjunct therapy following TURBT (Anastasiadis & de 
Reijke, 2012). This is known as adjuvant intravesical therapy. The purpose of intravesical 
therapy is to prevent tumour recurrence by killing cells before they begin to grow 
(Anastasiadis & de Reijke, 2012). Intravesical therapy is delivered in an outpatient setting, 
via a catheter which is inserted into the bladder (Anderson 2018a). There are two ‘gold 
standard’ intravesical treatments: bacillus Calmette-Guérin (BCG) and Mitomycin C. BCG is 
a type of immunotherapy often used for patients with CIS or patients with tumours at high 
risk of recurrence (Anderson, 2018a). BCG has been demonstrated to reduce the risk of 
progression of the cancer (e.g., Han & Pan, 2006). Mitomycin C is a chemotherapy treatment 
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most commonly used in patients with low grade tumours and at lower risk of recurrence 
(Anastasiadis & de Reijke, 2012).  
Survival rates for patients with NMIBC are positive but depend on a number of 
factors including early diagnosis. Chang et al. (2016) reported the survival rates to be as high 
as 75-80% after a decade, with better rates for those with lower grade tumours. However, 
rates of tumour recurrence are high. With low grade cancer (e.g., Stage T1) 
tumour recurrence is common although progression to MIBC is rare (Anastasiadis & de 
Reijke, 2012). For patients with CIS, tumour recurrence rates are reported to be over 50% 
(Anastasiadis & de Reijke, 2012). A number of reports have described that BCG lowers the 
tumour recurrence rates from 19-37% compared to patients who do not receive intravesical 
therapy (e.g., Sylvester, van der Meijden, & Lamm, 2002; Witjes et al., 2016). There is 
debate within the literature as to whether BCG prevents or postpones tumour recurrence and 
progression to MIBC (Thiel et al., 2019). Research has found that after five years, around 
50% of patients who receive BCG can have a tumour recurrence which can lead to 
progression of the cancer (Woldu, Şanli, & Lotan, 2017). Similarly, Witjes et al. (2016) 
reported that the risk of progression for high grade tumours (e.g., CIS) is around 50% after 
five years. Thiel et al. (2019) found that the use of BCG therapy in patients with high grade 
NMIBC lessened tumour recurrence and advancement in the long term. If NMIBC progresses 
to MIBC, it can be treated with a cystectomy (removal of the bladder) and/or chemotherapy 
(Sanli et al., 2017). Cystectomy is a radical treatment with a relatively high morbidity rate 
and clear implications for the individual who may have to live with incontinent means of 
managing urine output (stoma and appliance). It is clear that BC is a serious disease which 
requires invasive treatment and ongoing surveillance. Furthermore, different treatment and 
surveillance approaches can bring about a number of difficulties for patients over time. 
Patients have reported pain, infections, toileting issues (urinary) and gastro-intestinal 
complications (Rutherford, Costa, King, Smith, & Patel, 2017). This demonstrates the 
physical burden on patients in the short and long term.  
While the clinical burden of BC has been presented, it is important to outline the 
economic liability of the disease. BC is very costly for a number of reasons. As demarcated, 
it has a high rate of recurrence and requires long term follow-up and surveillance. For 
example, cystoscopies are an expensive procedure. Sievert et al. (2009) reported that BC is 
the costliest cancer to treat worldwide per patient. This finding underpins the multifaceted 
difficulties associated with the disease. 
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2.2.6: BC and Comorbidity 
Comorbidity is defined as a co-occurring illness/disease/condition alongside the 
primary disease which in this case is NMIBC (Megwalu, Vlahiotis, Radwan, Piccirillo, & 
Kibel, 2008). Risk factors for the development of BC have been well documented and include 
advancing age and lifestyle factors such as smoking (Anderson, 2018b). It is possible that 
many patients with NMIBC may also have additional health problems. As BC is most 
commonly found in older patients, it is probable that patients may already have additional 
health conditions due to their age. An early longitudinal study found that over 50% of BC 
patients have a co-morbid condition (Coebergh, Janssen-Heijnen, Post, & Razenberg, 1999). 
In a review of patients with BC, Megwalu et al. (2008) found that 446 of 675 patients (66%) 
presented with one or more coexisting illness. Due to the association of smoking with BC, 
patients often have co-existing diseases related to smoking including cardiovascular and 
pulmonary problems (Roy, Vallepu, Barrios, & Hunter, 2018). Furthermore, in a study of 
over 10,000 patients with BC, it was found that patients were 60% more likely to receive a 
diagnosis of a secondary cancer (e.g., lung and prostate cancer) compared to the general 
population (Muller et al., 2016). Intuitively, the presence of co-morbid diseases is related to 
survival rates among patients with NMIBC and MIBC (Konety, 2008). Thus, patients with 
BC are likely to experience a co-existing illness and the presence of a co-morbidity is related 
to mortality rates. 
 
2.3: BC and its Impact on a Range of Social and Psychological Outcomes 
2.3.1: Psycho-Social Outcomes in Cancer Patients 
Due to improvements in medicine and health care, cancer survival rates have 
increased (Rowland et al., 2013). A number of literature and systematic reviews have 
described the long term impact of cancer on general wellbeing and functioning including 
physical limitations, cognitive difficulties, pain, sexual problems and mental health 
difficulties (e.g., Harrington, Hansen, Moskowitz, Todd, & Feuerstein, 2010; Niedzwiedz, 
Knifton, Robb, Katikireddi, & Smith, 2019; Rathod, Livergant, Klein, Witterick, & Ringash, 
2015).  
Advancing age, being male, and a cancer diagnosis are all risk factors for 
experiencing psychological distress (Draeger, Sievert, & Hakenberg, 2018; Irwin, 2013; Kok 
and Reynolds, 2017). A meta-analysis reported the prevalence rates of major depression and 
anxiety disorders in cancer patients as 15% and 10% respectively (Mitchell et al., 2011). 
Depression and anxiety were found to be more prevalent in long-term cancer survivors 
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relative to control participants (Krebber et al., 2014). BC patients are likely to have some of 
the risk factors associated with increased psychological distress. Therefore psychological and 
social functioning outcomes in BC patients will be explored.  
 
2.3.2: Psycho-Social Outcomes in BC Patients 
Section 2.2 of the literature review described BC and delineated its impact on the 
body in terms of symptoms, diagnosis, treatment, rates of recurrence and survival rates. 
NMIBC is a complex and burdensome health problem due to its high rates of recurrence, 
variable responses to treatment and high probability of a co-existing disease. Naturally, it is 
important to consider the association between BC and its impact on an individual’s quality of 
life and mental health. 
Very few studies have investigated the impact of BC on psycho-social outcomes. 
Moreover, much of the research has focused on patients with MIBC rather than NMIBC. For 
example, in a recent appraisal of the literature, Taarnhøj, Johansen, and Pappot (2019) carried 
out the first systematic review examining quality of life studies with MIBC patients receiving 
treatment. Many of the studies reviewed were considered to be methodologically flawed due 
to their inclusion of cross-sectional designs, retrospective research and small sample sizes. 
Therefore, interpretation of the findings is tentative. Very few studies investigated mental 
health outcomes and thus psychological functioning could not be accurately determined 
(Taarnhøj et al, 2019). Synthesised findings, from the review, described that patients with 
MIBC were likely to experience urinary and sexual functioning difficulties. Given the lack of 
clarity, it is argued that more research is necessary to better understand psychological 
wellbeing outcomes in BC patients. 
Regarding NMIBC, there is limited research that has examined psycho-social 
outcomes and of the existing literature, it is mostly cross-sectional. Nevertheless, the existing 
research will be explored. A selection of empirical research studies compared outcomes 
between MIBC and NMIBC patients. A recent large-scale cross-sectional study found that 
quality of life outcomes was lower for patients with MIBC compared to NMIBC, with newly 
diagnosed patients experiencing the lowest scores (Chung et al., 2019). Chung and colleagues 
(2019) also described that many patients, in both groups, had unmet needs and required 
information about their physical health, practical matters and medical information. However, 
results from the existing empirical research are variable and sometimes contradictory. For 
example, Yu and colleagues (2019) found no difference between health-related quality of life 
scores between MIBC and NMIBC patients around the time of initial diagnosis. Interestingly, 
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the authors reported that quality of life scores were relatively high for both groups. However, 
this piece of research was not prospective and only examined quality of life following 
diagnosis. Therefore, it is difficult to discern the value of the findings of this particular study. 
In another study, Smith and colleagues (2018) sought to examine quality of life following 
diagnosis in older BC patients compared to matched controls. This study comprised of 77 
MIBC, 458 NMIBC and 770 control participants. There are a number of findings that are 
worth describing, in particular that patients with BC had a reduced quality of life across many 
domains of their life, relative to controls including their physical, social and mental health 
(Smith et al., 2018). The study deduced that patients with NMIBC were as vulnerable to 
deleterious mental health outcomes as patients with MIBC, underlining the impact that the 
disease can have on an individual. Therefore, it may be possible to discern that BC (both 
MIBC and NMIBC) patients are vulnerable to experiencing negative psycho-social outcomes 
following diagnosis and treatment. Current research has failed to fully address the psycho-
social impact on patients with NMIBC. A mismatch exists in the literature, whereby it has 
mainly focussed on patients with MIBC. With this gap in mind, it is necessary to tease apart 
what these specific implications are for NMIBC patients.  
 
2.3.3: Psycho-Social Outcomes in NMIBC Patients 
Although the preceding paragraphs have delineated that the available empirical 
research is inconsistent, it is posited that patients with NMIBC can experience deleterious 
psychological and social outcomes. A number of research studies have yielded findings 
which have demonstrated the burden on NMIBC patient’s wellbeing. For example, van der 
Aa and colleagues (2008) confirmed that regular surveillance for patients, including frequent 
cystoscopy procedures was associated with pain and discomfort for around one third of 
patients. Additionally, Yoshimura and colleagues (2005) demonstrated that patients with 
NMIBC perceived their health more negatively compared to control participants. 
Furthermore, it was found that patients on surveillance displayed reduced physical health 
functioning and impairments in social and mental health domains particularly during their 
first number of medical procedures (Yoshimura et al., 2005). Patients with NMIBC were 
more likely to report sexual functioning problems compared to age and gender matched 
controls in the general population (van der Aa et al., 2009). Perhaps unsurprisingly, patients 
with NMIBC exhibited greater decreases in health specific quality of life outcomes, 
particularly physical health and urinary function relative to control participants who did not 
have cancer (Brisbane et al., 2019). The authors further noted the deleterious impact of 
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NMIBC on patients’ mental health outcomes relative to control participants (Brisbane et al., 
2019). Given the outlined findings, it is possible to conclude that NMIBC patients experience 
more negative psycho-social outcomes across many domains of their life compared to the 
general population. 
In order to address the dearth of research on NMIBC patients, Jung et al. (2019b) 
investigated the effects of BC and its medical treatment on patients’ psycho-social outcomes, 
with a particular focus on the impact of physical health. Around 400 patients with NMIBC 
reported difficulties with sleep, fatigue, pain, sexual functioning and financial issues (Jung et 
al., 2019b). Jung and colleagues (2019b) additionally reported that patients with NMIBC 
reported worsened psychological health, over time. Although, results of the study 
demonstrated that there is a persistent negative impact on patients’ wellbeing over time, the 
findings should be interpreted with caution because it was a cross-sectional study.  
Jung and colleagues (2019a) carried out a systematic review of psycho-social 
outcomes in patients with NMIBC in an attempt to synthesise and better understand the 
available research, particularly because the majority of the current research has focussed on 
the effects on patients with MIBC. The systematic review examined psycho-social outcomes 
in NMIBC patients during diagnosis and after treatment. It comprised of fifteen studies 
(fourteen quantitative and one mixed methods). Similar to other findings regarding BC 
treatment, repeated tumour resections and intravesical therapy were associated with poorer 
physical health outcomes, particularly pain, bowel and urinary issues (Jung et al., 2019a). 
Short term psycho-social outcomes for NMIBC and MIBC patients were comparable (Jung et 
al., 2019a). However, the focus of the studies was often narrow, typically only examining the 
impacts of the disease on physical health outcomes. Both NMIBC and MIBC patients 
experienced an exacerbation of physical health functioning in the decade after diagnosis, 
demonstrating that the physical impacts for NMIBC patients are at least as significant as that 
of MIBC patients. Perhaps unsurprisingly, it was found that patients with NMIBC had worse 
overall quality of life outcomes (physical, mental and social) in comparison to the general 
population (Jung et al., 2019a). BC was also associated with worsened psychological health. 
An unanticipated finding was that patients with NMIBC reported diminished mental health 
outcomes in the five years following diagnosis while the same finding was not found for 
patients with MIBC (Jung et al., 2019a). While, the number of studies in the systematic 
review were relatively small, a number of conclusions can be drawn from the findings. 
Significantly, it appears that the impact of NMIBC on both physical and psycho-social 
outcomes is analogous, in some respects, to having the MIBC. Furthermore, the authors 
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helpfully described a number of gaps in the current literature which comprised of the 
following. It was pointed out that there is a shortage of research examining psychological 
wellbeing outcomes for NMIBC patients and many of the available studies are of poor 
quality. In addition, it was expressed that much of the literature is primarily concerned with 
the impact of the disease on physical health domains. Burgeoning empirical research has 
acknowledged the impact of the NMIBC on psychological wellbeing outcomes. Thus, greater 
investigation is warranted in order to better understand the psychological well-being of 
NMIBC patients in the continuum of diagnosis, treatment, surveillance and recovery. 
 
2.3.4: Mental Health Outcomes in NMIBC Patients 
Section 2.3.3 clearly delineated the growing need for research investigating the effects 
of NMIBC on emotional distress. As outlined, NMIBC patients are in the rare position of 
requiring extensive surveillance over time due to the high recurrence rates of tumours. This 
means that many patients live in a ‘limbo’ state where there is always the possibility of BC 
recurrence requiring further treatment. It is apparent that BC patients may be vulnerable to 
experiencing mental health difficulties due to their illness. Therefore, it is necessary to 
disentangle the existing literature and consider whether or not patients living with NMIBC 
are at greater risk of experiencing psychological distress. 
Three recent reviews attempted to synthesise the available data regarding 
psychological distress in patients with BC (Pham et al., 2019; Vartolomeia, Ferroc, Mironed, 
Shariata, & Vartolomeia, 2018; Vartolomei, Vartolomei, & Shariat 2019). Of these, 
Vartolomeia and colleagues (2018) systematically reviewed thirteen studies which examined 
the prevalence of anxiety and depression in BC patients. BC was not categorised according to 
MIBC and NMIBC. However, it was found that psychological distress was highly prevalent 
at diagnosis, treatment, surveillance, and recovery for patients with BC (Vartolomeia et al., 
2018). In another review, Vartolomei and colleagues (2019) established that a diagnosis of 
BC is a risk factor for increased psychological distress. Pham and colleagues (2019) carried 
out a systematic review which summarised mental health outcomes at diagnoses and during 
treatment for BC patients. Reviewed research encompassed the year 2000 to 2018, and only a 
small number of studies met criteria for inclusion within the review. Eleven empirical studies 
had been carried out with MIBC patients and six which combined MIBC and NMIBC 
patients (Pham et al., 2019). Only 2 studies examined mental health outcomes in patients with 
NMIBC. Interestingly, the authors described that the research findings did not demonstrate 
any differences in psychological health outcomes between patients with MIBC and NMIBC, 
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albeit reporting a trend of worsened psychological distress with a more advanced disease 
stage (Pham et al., 2019). Regarding the outcomes for NMIBC patients, it was found that 
diagnosis and repeated TURBT surveillance resulted in increased psychological distress. 
Definitive answers cannot be yielded from this systematic review due to the small number of 
studies. However, findings from the review demonstrated that BC is associated with 
increased emotional distress.  
Depression and anxiety are the most common psychological problems that patients 
are likely to experience following a BC diagnosis and during treatment, particularly for 
patients with a history of mental health difficulties (Pham et al., 2019). Given that, there is 
some evidence to suggest that NMIBC patients are as likely to experience psychological 
distress as patients with MIBC (Jung et al., 2019a; Pham et al., 2019) more research is 
required to fully understand the psychological burden on patients with NMIBC.  
2.4: Illness Perceptions Literature 
2.4.1: The Self-Regulation Model of Common Sense Illness Representations 
(SRM) 
Cancer patients are presented with many challenges. Naturally, patients have to make 
sense of their illness, cognitively and emotionally, and subsequently cope with it. The way in 
which patients perceive and manage their illness will be considered in the context of a 
psychological theoretical model. Theoretical models provide a structured way of 
understanding the way in which people perceive health problems and generate coping 
responses. The SRM is an empirically supported theoretical model and will be outlined in 
detail (Leventhal, Nerenz, & Steele, 1984). It is a well-established theoretical model which 
delineates the processes underpinning health and coping in people with an illness (Hagger & 
Orbell, 2003).  
Other theoretical frameworks were considered and ultimately discounted based on 
suitability. For example, the Health Belief Model (HBM) is an empirically supported 
theoretical model that conceptualises the way in which individuals take action to manage 
their illness (Rosenstock, Strecher, & Becker, 1988). The HBM proposes that perceptions 
about the seriousness of the illness, benefits and barriers to a health behaviour and self-
efficacy predict engagement in health related behaviours (Champion & Skinner, 2008). This 
model was ultimately disregarded because it predicts health related behaviours. It was 
considered unsuitable for this study because this research was interested in how perceptions 
of illness and coping influence psychological distress. Additionally the HBM was discounted 
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because it does not consider emotional representations of illness (Champion & Skinner, 
2008). 
 The definition and an overview of the SRM will be provided. The SRM was initially 
developed by Leventhal and colleagues (1984) in order to have a framework for 
understanding how people’s experience of illness symptoms and emotions, during a threat to 
their health, affects their perceptions of illness and coping. Illness beliefs refer to the patient’s 
personal implicit thoughts about their illness (Leventhal et al., 2003). The model 
conceptualises the way in which information about the illness is assimilated in order to make 
sense of the illness and cope with it (Llewellyn, McGurk, & Weinman, 2007). The SRM 
contains a number of assumptions, primarily that people are active in their problem solving 
(Leventhal et al., 1998). It also contends that individuals create multifaceted cognitive and 
emotional perceptions of their illness.  
 The SRM conceptualises that, when a person perceives that there is a threat to their 
health, they access cognitive and emotional perceptions of the threat based on illness stimuli 
(Leventhal et al., 2003). Illness stimuli refers to pre-existing lay or cultural knowledge about 
the illness, information received from the social environment (including from health care 
professionals and significant others), previous illness experiences and the type and severity of 
somatic symptoms associated with the threat (Leventhal et al., 1998). Hopman and Rijken 
(2015) identified that personal and familial experiences, socio-cultural factors and education 
influence illness perceptions. 
According to the model, perceptions about health threats are generated and 
corresponding psychological representations influence coping responses in a parallel process 
(Diefenbach & Leventhal, 1996). More specifically, individuals acquire cognitive and 
emotional representations of illness, known as illness perceptions, when they experience a 
health problem. There is a parallel process between illness perceptions and emotional 
representations that guide selection of coping strategies which ultimately influence patient 
outcomes such as psychological distress (Diefenbach & Leventhal, 1996). The model is 
dynamic. New information and changes in symptoms can bring about a re-appraisal of illness 
perceptions that subsequently influence representations and coping responses (Hale, 
Treharne, & Kitas, 2007). It is important to note that illness perceptions only guide the 
response to the illness through coping. Patients also participate in appraising their selected 
coping strategies. Every stage of the SRM has a feedback loop to each of the previous stages. 
Thus, appraisal of coping strategies can influence illness stimuli and illness perceptions. 




Figure 1: A conceptualisation of the SRM (adapted from Hagger & Orbell, 2003). 
 
 The SRM has arranged illness perceptions into separate dimensions: Identity, Cause, 
Timeline, Consequences, Control (Personal and Treatment), Illness Coherence and Emotional 
Representations. Each dimension will be described in detail. The dimension ‘Identity’ refers 
to the ‘what is it?’ of the illness. It is the individuals perception of the ‘label’ of the illness as 
well as their beliefs about the symptoms (Leventhal, Leventhal, & Contrada, 1998). The 
‘Cause’ dimension signifies the patients belief about what brought about the illness, i.e., the 
‘why’ of the illness. (Leventhal et al., 1998). Patients can perceive their illness to be caused 
by one or a combination of biological, emotional and environmental factors (Hagger & 
Orbell, 2003). The ‘Timeline’ dimension is the patient’s beliefs about the timeframe of the 
illness, particularly regarding their illness development, duration and recovery (Leventhal et 
al., 1998). It also concerns beliefs about whether the illness is acute, chronic or cyclical in 
nature (Richardson, Schüz, Sanderson, Scott, & Schüz, 2017). The fourth dimension is 
referred to as ‘Consequences’ and relates to the factors of the illness that the person believes 
will affect their daily functioning, in terms of physical health, social and mental health 
functioning (Leventhal et al., 1998). It is the ‘what will happen to me?’ of the illness. These 
beliefs encompass both factual and imagined thoughts about illness. The last of the original 
dimensions is known as ‘Control’ and essentially refers to the patients beliefs about the 
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controllability of the illness and/or whether or not it can be cured (Leventhal et al., 1998). It 
is the ‘what can be done?’ of the illness and encompasses beliefs about what can be done to 
have ‘control’ over the disease through individual means or other means such as medical 
treatment (Richardson et al., 2017). Within the literature, this dimension has sometimes been 
split in to two categories to better explain it – and it is referred to as ‘Personal Control’ and 
‘Treatment Control’ (Richardson et al., 2017). Following the creation of the first five 
dimensions, Illness Coherence and Emotional Representations were later added to the model. 
The dimension ‘Illness Coherence’ simply refers to the extent to which the patient 
understands their illness in a coherent manner. Moss-Morris et al. (2002) described it as the 
way in which patients consider their illness as a whole. The extent to which the individual 
perceives that their illness is emotionally impactful describes the ‘Emotional Representations’ 
including feelings of fear, anxiety and depression in relation to the illness (Moss-Morris et 
al., 2002). To conclude, the SRM was considered a good fit for this research because it is a 
comprehensive and empirically supported theoretical model that describes how a person 
understands and copes with their illness. Additionally, the dimensions of the SRM form a 
coherent explanation of illness perceptions. With this in mind, it is necessary to explore how 
illness perceptions are measured. 
 
2.4.2: Measuring Illness Perceptions  
The assessment of illness perceptions has a long history in the empirical literature. 
Illness perception dimensions are typically assessed through the use of quantitative 
measurement. The first psychometric questionnaire, the Illness Perceptions Questionnaire 
(IPQ), measured the original five dimensions of illness perceptions (Weinman, Petrie, Moss-
Morris, & Horne, 1996). The IPQ was ultimately revised to the Illness Perceptions 
Questionnaire Revised (IPQ-R). It was revised in order to amend the original questionnaire 
by adding two new dimensions, outlined previously (Moss-Morris et al., 2002). It was argued 
that the additional dimensions added a greater understanding of illness, and it has good 
psychometric properties including reliability and validity (Moss-Morris et al., 2002). A Brief 
Illness Perceptions Questionnaire (Brief IPQ) was created by (Broadbent, Petrie, Main, & 
Weinman, 2006) and offers a quick assessment of illness perceptions. In a systematic review 
of over 180 research studies, Broadbent and colleagues (2015) found the Brief IPQ to have 
good psychometric properties and advocated for its use in research. However, Revenson and 
Diefenbach (2019) recently questioned all of the currently available questionnaires abilities to 
accurately capture representations of illness due to their possible oversimplification of the 
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complexity of the model and called for more innovative ways of examining illness 
perceptions. Qualitative research methods such as semi-structured interviews may 
complement the use of quantitative measures and add to our understanding of illness 
perceptions. 
 
2.4.3: Illness Perceptions, Coping and Patient Outcomes 
 The literature has shown robust findings for illness perceptions and coping and their 
consistent relationship to patient outcomes. Hagger and Orbell (2003) carried out the first 
meta-analytic review which synthesised the available research in order to provide a better 
understanding of the SRM and how illness perceptions relate to coping and illness outcomes 
across a range of illnesses. It demonstrated reliability and validity of the IPQ and IPQ-R. The 
meta-analysis comprised of 45 studies. In the review, none of the studies had examined 
cancer patients and only one of the studies had researched patients at risk of cancer. Results 
found that the illness perceptions constructs were related to coping and patient illness 
outcomes (Hagger & Orbell, 2003). This finding was demonstrated across many illnesses, 
both chronic and acute. The findings delineated that patients with strong Controllability 
beliefs engaged in more adaptive coping behaviours. Stronger Identity and Timeline beliefs 
about illness were associated with maladaptive coping. Patients who considered their illness 
to be Controllable had better outcomes specifically with their physical, emotional and social 
well-being (Hagger & Orbell, 2003). While patients who held more negative Identity, 
Timeline and Consequences beliefs experienced more deleterious outcomes particularly 
regarding their physical, social and mental health functioning (Hagger & Orbell, 2003).  
In a more recent meta-analytic review, Dempster, Howell, and McCorry (2015) 
examined the degree to which illness perceptions and coping explained psychological distress 
in people with a physical health problem, determining that between 25 and 30% of the 
variance is accounted for by illness perceptions. Additionally, coping was found to be a 
strong predictor of psychological outcomes. Similarly, a number of systematic and meta-
analytic reviews have demonstrated the relationship between illness perceptions and patient 
outcomes, including quality of life and psychological distress (Aujla et al., 2016; Hagger, 
Koch, Chatzisarantis, & Orbell, 2017; Rivera, Corte, DeVon, Collins, & Steffen, 2020). The 
research has provided evidence for the SRM by demonstrating the relationship between 
illness perceptions, coping and psychological outcomes. 
 
2.4.4: Illness Perceptions, Coping and Patient Outcomes in Cancer Patients  
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The illness perceptions literature with respect to cancer patients will now be reviewed. 
The current research is primarily cross-sectional and has been conducted with patients who 
have a specific cancer diagnosis. For example, research has examined illness perceptions 
among patients with lung cancer (Kaptein, Yamaoka, Snoei, Kobayashi, & Uchida, 2011), 
breast cancer (Anagnostopoulos & Spanea, 2005; Karabulutlu et al., 2019), head and neck 
cancer (Llewellyn, McGurk, & Weinman, 2007), prostate cancer (Traeger, Penedo, Dahn, & 
Lechner, 2009), ovarian cancer (Lancastle, Brain, & Phelps, 2011) gastrointestinal cancer 
(Miceli et al., 2019) and oesophageal cancer (Dempster et al., 2012). The findings have been 
inconsistent, with some studies demonstrating that more negative illness perceptions and 
maladaptive coping are associated with worse mental health outcomes and poorer physical 
functioning, while other studies have found less significant effects. A systematic review of 
breast cancer patients found that illness perceptions varied by individual and by culture 
(Kaptein et al., 2015). Kaptein and colleagues (2015) found that illness perceptions influence 
quality of life outcomes, including emotional distress. 
In an attempt to synthesise the research pertaining to cancer patients Richardson and 
colleagues (2017) carried out a systematic review and meta-analysis on 54 studies examining 
illness perceptions, coping and outcomes in patients with cancer. Findings were broadly in 
line with the Hagger and Orbell (2003) review. Most of the studies reviewed examined 
patients with breast, prostate and head and neck cancer. Other cancer diagnoses were 
included, however BC was not cited as a diagnosis that had been researched. Stronger 
Emotional Representations was related to higher levels of avoidance and denial (maladaptive 
coping). Strong Personal Control beliefs was related to greater use of problem-focused 
coping (adaptive coping). Effect sizes on patient outcomes were variable and heterogenous. 
Stronger Emotional Representations and Consequences perceptions were the best predictor of 
emotional distress. Reduced Identity perceptions was associated with better physical health 
and quality of life (Richardson et al., 2017). The review demonstrated evidence for the 
applicability of the SRM in understanding illness perceptions, coping and psychological 
wellbeing in patients with cancer. 
Two studies have examined illness perceptions in NMIBC patients. Tan and 
colleagues (2020) found that NMIBC patients had low perceptions of Personal Control and 
perceived the Timeline of their illness to be chronic. The authors did not examine coping and 
psychological distress in the context of the SRM (Tan et al., 2020). In the only study that has 
examined illness perceptions as a predictor for psychological distress in patients with 
NMIBC, it was found that stronger perceptions of Consequences, Identity, Timeline and 
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Emotional Representations predicted psychological distress at three and twelve months 
following diagnosis (Zhang et al., 2019). The study did not examine coping and thus did not 
examine NMIBC in the context of the full SRM. However, these findings demonstrate some 
burgeoning evidence for the applicability of the SRM to NMIBC.  
A number of studies have attempted to gain a greater understanding of illness 
perceptions in cancer patients by using qualitative methods. For example, in an early study 
Savage and Clarke (1998) recognised the shortcomings of assessing theoretical models using 
quantitative methods and employed the use of a qualitative design to examine the SRM. The 
study assessed older women’s illness perceptions about screening for cervical and breast 
cancer and found that there were some inconsistencies in the results that did not match the 
SRM. For example, regarding illness Identity, some participants held the view that they 
would know if they had cancer without being tested, and in the absence of symptoms. Later, 
Richardson, Scott, Schüz, Sanderson, and Schüz (2017) found that patients with cancer and 
anxiety/depression expressed diverse illness perceptions and some participants perceived 
their emotional distress to be a causal factor in their cancer diagnosis. Koenigsmann, Koehler, 
Regner, Franke, and Frommer (2006) qualitatively explored illness perceptions in patients 
with acute leukaemia one week after diagnosis and found rich data pertaining to the impact of 
the diagnosis on the patients whole identity. The authors described the significant burden on 
patients and fears about treatment and mortality, going beyond the constructs of the SRM. In 
another study with patients with gynaecological cancer, the authors found that qualitative 
interviews helped to better understand the experience of patients. Phillips, Montague, and 
Archer (2017) described the complex and changing nature of illness identity from diagnosis, 
through treatment and recovery, noting that patients goals for recovery change with time. The 
use of qualitative methods can help to test the validity of the SRM in patients with illnesses. 
It was noted that exploring illness perceptions qualitatively is not commonly seen in the 
literature, despite its ability to achieve a greater insight in to patients perspectives of illness.  
 
2.4.5: The Lived Experience of Patients with BC  
There is limited research available that has utilised a psychological theoretical model 
when exploring the impact of NMIBC during diagnosis, treatment and surveillance, 
particularly in a qualitative context. However, a small number of studies have qualitatively 
explored the lived experience of NMIBC patients, without the use of a theoretical model. For 
example, Clark and colleagues (2015) interviewed ten high risk patients with NMIBC about 
their medical treatment. While it did not draw from a theoretical framework, if found that 
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most patients reported pain/discomfort related to their treatment but were satisfied with the 
treatment. Interestingly, most patients did not report emotional distress as a result of their 
diagnosis and treatment (Clark et al., 2015). Furthermore, a common theme described that 
patients were positive in their outlook about the disease and considered it a ‘good’ cancer 
compared to others. Some patients indicated that the disease had not impacted on their lives 
(Clark et al., 2015). The authors identified the need for more psychological research 
regarding patients experiences of the disease particularly concerning NMIBC patients’ 
perspectives of diagnosis, treatment and psychological outcomes. 
Edmondson, Birtwistle, Catto, and Twiddy, (2017) carried out a systematic review of 
BC patients’ experience of diagnosis and treatment from fourteen qualitative studies. 
Notably, the reviewers included studies with patients at all stages of BC, urinary cancer and 
other cancers. Additionally, patients had received a range of medical treatments. Only four of 
the studies qualitatively examined NMIBC patients. The findings highlighted the lack of 
research available and the subsequent challenges drawing inferences from the findings. Only 
two studies examined patients’ experience of TURBT, commenting that physical symptoms 
were temporary (Edmondson et al., 2017). Impact of the treatment was described particularly 
with reference to difficulties with toileting and sexual functioning. Quality of life following 
treatment was mixed for all groups of patients and changed over time (Edmondson et al., 
2017). Regarding the fear of cancer recurrence, a common theme described was facing the 
problem as it arises and keeping an optimistic attitude. The authors reported difficulties in 
drawing conclusions about NMIBC patients because most of the qualitative research 
pertained to MIBC. Additionally, none of the research utilized a theoretical model to guide 
the research. Edmondson and colleagues (2017) identified clear gaps in the literature and 
called for greater qualitative research to understand NMIBC patients experience of illness, 
treatment and psychological outcomes. 
 
2.5: Current Study 
A gap in the literature exists pertaining to NMIBC patients’ illness perceptions. 
Findings within the literature are confounded by research limitations including studies 
frequently examining BC patients at all stages of the disease and the use of only cross-
sectional research designs. 
A mixed methods design was chosen to provide a source of data triangulation from 
which a better understanding of illness perceptions, coping and psychological distress in the 
context of the lived experience of NMIBC might be achieved. The primary aim of this study 
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was to investigate the illness perceptions, coping strategies, emotional distress and experience 
of patients on surveillance who have received treatment for NMIBC. It is an exploratory 
study, underpinned by the SRM. The SRM matches well to qualitative methodology (e.g., 
interpretative phenomenological analysis) because it examines experiences (Leventhal et al., 
1998). Due to the dynamic nature of the SRM and its constructs, it is a helpful way to clarify 
patients’ experiences and the impact of the disease. 
 
2.5.1: Quantitative Aims and Hypotheses 
There is a paucity of research which has investigated illness perceptions, coping and 
psychological distress in patients with NMIBC on surveillance in routine clinical settings. 
The principal aims of the quantitative part of the study are to a) examine illness perceptions 
in patients with NMIBC and b) explore the relationship of illness perceptions and coping to 
psychological distress within the population.  
 
The research questions were as follows: 
What illness perceptions do patients with NMIBC have? 
What is the relationship between illness perceptions and coping to psychological distress? 
To what extent do illness perceptions and coping strategies explain psychological distress in 
patients with NMIBC?  
 
In the literature, patients with stronger illness perceptions scores on the Identity, 
Consequences, Timeline, Concern and Emotional Representations constructs rate their 
psychological distress as more severe. Patients with stronger illness perceptions scores on the 
Control and Coherence constructs rate their psychological distress as less severe.  
 
Therefore, in the present study it was hypothesised that: 
a) More negative perceptions of NMIBC would be associated with higher levels of 
psychological distress (anxiety and depression). 
b) Use of avoidance-based coping strategies would be associated with higher levels of 
psychological distress. 
c) Use of approach-based coping strategies would be associated with lower levels of 
psychological distress. 
 
 2.5.2: Qualitative Aims and Hypotheses 
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Given the possible limitations of quantitative measures of illness perceptions 
(Revenson & Diefenbach, 2019), there is a gap in the literature regarding a more 
comprehensive assessment of illness perceptions in patients with an illness. As far as the 
researcher is aware, there is currently no qualitative research available that has explored 
illness perceptions, coping and psychological distress in patients with NMIBC on 
surveillance, within the context of the full SRM. 
The aim of the qualitative part of the study was to provide a thorough understanding of the 
patients’ perspectives of their illness. It was hoped to go beyond the quantitative measures to 
achieve insight into the lived experience of the illness. 
Therefore, the research question was: How do patients with NMIBC experience their illness 
























Chapter 3. Methodology 
3.1: Introduction to Method – Design 
 In this chapter a rationale for the use of both quantitative and qualitative methods are 
documented. A description is provided of both the participants and the measures used in the 
study. Data collection and analysis procedures are outlined. Finally, ethical considerations are 
addressed and discussed. 
 
3.2: Research Design 
3.2.1: Rationale for use of Quantitative Research Methodology 
One of the principal aims of the study was to examine the illness perceptions of 
patients on surveillance who had received treatment for NMIBC. Cross-sectional and 
correlational research provides a platform for detailed analysis between dependent variables 
(DV) and independent variables (IV). In this study the DV’s are psychological distress 
(anxiety and depression) and the IV’s (predictor variables) are illness perceptions and coping 
strategies. This type of research design is useful when examining a large group of participants 
because it allows the researcher to establish patterns in the data.  
It has been well documented that there are only two studies that have applied the 
SRM to the study of NMIBC. Therefore, application of the model when examining 
psychological distress among patients with NMIBC can serve as a way to clarify the 
relationships between illness perceptions, coping and psychological distress outcomes. Use of 
well validated quantitative measures provides the opportunity to test the utility of the SRM in 
predicting psychological distress in NMIBC patients. Quantitative examination of the SRM 
with respect to NMIBC provides contiguity between the quantitative and qualitative strands 
of the research. Furthermore, non-experimental designs, similar to this study, have been 
identified as a method of developing psychological interventions to support patients (Vance, 
Talley, Azuero, Pearce, Christian, 2013). It is hoped that through increasing the knowledge 
base in this area, it contributes to the further development of evidence based psychological 
practice in the treatment of NMIBC patients.  
 
3.2.2: Rationale for use of Qualitative Research Methodology 
 One of the principal goals of the research was to better understand the personal and 
lived experiences of patients with NMIBC. Qualitative research allows the researcher to gain 
insight into a person’s experiences and behaviours (Braun & Clarke, 2013). Given that the 
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purpose of the study was to get a clearer understanding of the beliefs, perceptions, coping and 
psychological wellbeing of patients with NMIBC, qualitative research was considered an 
appropriate methodology.  
 Qualitative research is embedded in epistemology (Creswell, 2013). This means that 
the purpose of a qualitative research design is to understand lived experiences, relationships 
among phenomena and interpret events and experiences by identifying and investigating 
patterns in the data (Braun & Clarke, 2013). This, therefore, renders use of a qualitative 
methodology appropriate to this piece of research. Lastly, qualitative research is helpful as a 
way to examine less well understood topics (Creswell, 2013).  
 
3.2.3: Interpretative Phenomenological Analysis (IPA) 
A qualitative approach was suitable, in this instance, because the research question 
was focused on making meaning of and interpreting life experiences in the context of 
NMIBC. IPA was chosen as the most appropriate methodology to answer the qualitative 
research question. This was because the focus of the research was to elucidate the patients’, 
perceptions and experiences of their illness and the way in which they made sense of it. IPA 
investigates the lived experience of participants, giving voice to their experiences (Smith et 
al., 2009) which is particularly useful for an exploratory study. This study sought to make 
sense of the perspectives of the participant, in their own words, which makes IPA a good fit. 
Furthermore, IPA enables the researcher to gain detail about participants’ experiences by its 
flexible nature and by providing the opportunity for the participant to tell their story in their 
own way (Tuffour, 2017). Therefore, interpretations can be drawn about how life experiences 
are moulded within the socio-cultural and economic context of the participant (Tuffour, 
2017). 
The researcher considered other qualitative research methodologies and they were 
subsequently disregarded based on suitability. Thematic analysis was disregarded as it 
describes and summarises data rather than interprets phenomena (Braun & Clarke, 2006). 
Discourse analysis is focused on language where language constructs a person’s experience 
of their social world (Burck, 2005). It was considered unsuitable because the current study 
was devised to understand how participants make meaning from their experiences rather than 
focusing on the way in which they used language to describe their experiences. Finally 
grounded theory was disregarded as it aims to create a theory, grounded in the data, to 
explain particular phenomena (Charmaz, 2011). As explained, this study was embedded in 
the SRM. 
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 IPA is a type of qualitative research which is grounded in the analysis of how people 
make sense of experiences (Smith, Flowers, & Larkin, 2009). More specifically, it is focused 
on meaning and processes as distinct from events and their causes (Smith et al., 2009). Its 
research framework is rooted in 3 central principles; phenomenology, hermeneutics and 
idiography which are described in detail below. 
 To begin, phenomenology refers to a philosophical approach that is focused on 
examining experiences. More specifically, its purpose is to find out how an individual makes 
meaning from their personal and social world (Finlay, 2011). Smith et al. (2009) drew from a 
number of philosophers to delineate that in order to understand particular experiences, the 
spoken words of the participant are not sufficient. It was proposed that sense making happens 
when the researcher acknowledges their position in the research and attempts to understand 
the other’s world through interpretation. In other terms, it recognises that the researcher has 
their own life experiences, beliefs and perspectives that may influence the research because 
phenomenology requires the researcher to interpret rather than describe (Smith et al., 2009). 
 Hermeneutics describes the theory of interpretation in IPA. It examines how an 
experience appears and the way in which the researcher impacts on the reporting of the 
experience and thus enables its meaning making process (Smith et al., 2009). The term 
double hermeneutic refers to the researcher attempting to understand the experience of the 
individual who is himself/herself attempting to understand their own experience (Smith et al., 
2009). The double hermeneutic clearly recognises the impact of the researcher on the 
meaning making process. Therefore, this allows the researcher to reflect on their own beliefs, 
ideas and perceptions in order to manage their influence on the data analysis. Smith and 
colleagues (2009) describe the concept of the hermeneutic circle. It is concerned with the part 
and the whole of the spoken word. It is a dynamic process which means that in order to 
understand a particular part of the data, the whole conversation must be taken into account 
and to understand an entire interview, each part must be analysed (Smith et al., 2009).  
 Idiography refers to IPA’s emphasis on the particular, with respect to the detail and 
depth of analysis of each case (Smith et al., 2009). Therefore, it lends itself well to a small 
number of participants rather than large groups. This approach offers the opportunity for 
nuanced analysis at the individual level. Analysis at a group level is considered by firstly 
valuing each single case and then considering similarities and differences between 
participants (Tuffour, 2017). This makes it possible to discover new phenomena about 
particular life experiences, a significant strength of the approach (Smith, 2011). 
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3.2.4: Semi-Structured Interview 
 The semi-structured interview is considered very suitable for data collection in IPA 
research (Smith, 2011). It offers the opportunity for the participant to do the majority of the 
talking and the researcher to listen. Furthermore, it creates a structure to the collection of data 
(Smith et al., 2009). A semi-structured interview is malleable by nature and offers the 
possibility of collecting data on matters that arise during the interview that are not expected 
(Smith et al., 2009). This facilitates the researcher in collecting data about the phenomenon 
from the perspective of the individual. 
 
3.2.5: Rationale for use of a Mixed Methods Design 
 Given that this study employed the use of both quantitative and qualitative 
components, a rationale for the use of a mixed methods approach are provided. The strengths 
of a mixed method design are multi-fold. More specifically, a combination of approaches 
supports a deeper and more comprehensive understanding of the data analysis (Guével, 
Pommier, & Jourdan, 2015). It further helps to compensate for the limitations of using only 
one research design. The purpose of a quantitative design is to use statistical tests to better 
understand cause and effects relationships between selected variables, while qualitative 
designs serve to explore and interpret participants’ experiences (Creswell, 2009). A mixed 
methods approach offers the opportunity to more accurately answer the research question by 
giving an explanation of the results (Creswell & Plano Clark, 2007). 
 For the present study, it was exploratory in nature and comprised of both quantitative 
and qualitative research questions, in the context of the SRM. Therefore, the use of a mixed 
methods approach was considered a good fit as it served as a method of triangulation through 
the use of two methods of data collection. Essentially, for corroboration of the results to be 
achieved, a mixed methods design was suitable.  
 
3.3: Sampling 
3.3.1: Method of Sampling 
The quantitative and qualitative sampling methods are outlined. 
 
3.3.2: Quantitative Sampling Method:  
For the quantitative part of the study, a convenience sample was used comprising of 
patients with a diagnosis of NMIBC on surveillance attending a large hospital in the Southern 
part of Ireland. 
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3.3.3: Qualitative Sampling Method:  
For the qualitative part of the study, a purposive homogeneous method of sampling 
was utilised. This means that patients were chosen based on their ability to provide an in-
depth account into the particular experience, NMIBC, being researched (Smith et al., 2009). 
Participants were drawn from the pool of patients who had completed the quantitative part of 
the study. 
 
3.3.4: Sample size 
The quantitative and qualitative sample sizes are outlined. 
 
3.3.5: Quantitative Sample Size: 
 Eighty four patients completed the measures. One hundred and thirteen patients were 
approached to take part, thus there was a 60% response rate.  
 
3.3.6: Qualitative Sample Size:  
Ten patients participated in the qualitative part of the study. There is no clear 
agreement on the ‘correct’ number of participants appropriate to an IPA study. Brocki and 
Wearden (2006) put forward that small sample sizes are typical for an IPA study. Similarly, 
small sample sizes are appropriate as the focus is on understanding the depth of experience of 
each case (Smith & Eatough, 2007). With this in mind, the focus is on the quality of the 
interview and not the quantity that matters. Smith et al. (2009) reported that a sample size of 
between 4-10 participants is satisfactory for a doctoral research study. Particpants were 
recruited and analysed until data saturation was reached and no new information on the issues 
of interest was emerging. 
 
3.4: Inclusion and Exclusion Criteria 
Inclusion criteria comprised of patients attending the Urology Unit in the hospital 
with a diagnosis of NMIBC and on surveillance attending for a cystoscopy appointment or 
BCG treatment. The criteria required patients who spoke English as their first language 
because measures used were validated English versions, and who were able to provide 
informed consent to participate in the study. Patients could consent to do the quantitative 
piece of research and not consent to being interviewed for the qualitative piece.  
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Exclusion criteria ruled out patients who did not speak English as a first language and who 




The quantitative and qualitative recruitment protocols are outlined. 
 
3.5.2: Quantitative Recruitment Protocol: 
All participants were recruited from the Urology Department at the outpatient clinic. 
Once patients had checked in for their appointment, they were approached verbally by a 
research assistant. Patients were invited to join the study and were provided with an 
information sheet, if interested, which gave a detailed account of the study (see Appendix A). 
Participants were given time to read the information sheet and were asked if they had any 
questions about the nature of the study. Informed consent to participate was subsequently 
requested (see Appendix B). All participants were informed that not participating would have 
no impact, whatsoever, on their service now, or in the future. Participants were, additionally, 
given the opportunity to consider participation in their own time by taking the information 
sheet and informed consent sheet home, with a pre addressed stamped envelope to return. 
 
3.5.3: Qualitative Recruitment Protocol: 
 Potential participants were recruited from the group of patients who had completed 
the questionnaires. Patients were only contacted regarding the qualitative study if they had 
already expressed interest and consented to participating in an interview at the first stage of 
data collection. A reminder of the voluntary and confidential nature of the study was given at 
this point. For those who were interested in taking part, a time suitable for the patient to 
attend was arranged. Patients for both parts of the study were recruited from February 2019 to 
December 2019. This time frame was chosen to allow for sufficient time to recruit 
participants. 
 
3.5.4: Sample Characteristics 
The quantitative and qualitative sample characteristics are outlined. 
 
 3.5.5: Quantitative Sample Characteristics: 
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 Participants (N = 84) comprised 58 males (69%) and 26 females (31%). Their ages 
ranged from 39 to 86 years (M = 67.6, SD = 10.19). Table 1 below provides a detailed 
description of patient demographics. 
 
 3.5.6: Qualitative Sample Characteristics: 
 Participants (N = 10) were seven males and three females. Their ages ranged from 59 





Quantitative Participant Demographic and Treatment Variables Table  
 
Age        (M = 67.6, SD = 10.19, Range = 39-86) 
 
Years since diagnosis     (M = 5.46, SD = 5.35, Range = 0-24 years) 
 
Treatment 
Patients who received TURBT    (N = 66, 78.6%) 
Patients who received TURBT and BCG  (N = 18, 21.4%) 
 
Marital Status 
Single       (N = 17, 20.2%) 
Married/Living with Partner    (N = 47, 56%) 
Divorced/Separated     (N = 8, 9.5%) 
Widowed      (N = 12, 13%) 
 
Employment Status 
Employed      (N = 19, 22.6%) 
In Full-Time Education    (N = 0, 0%) 
Unemployed      (N = 7, 8.3%) 
Retired or Other     (N = 57, 67.9) 
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Have you ever experienced psychiatric problems? 
Yes       (N = 8, 9.5%) 
No       (N = 75, 89.3%) 
 
Current smoker  
Yes       (N = 14, 16.7%) 
No       (N = 70,  83.3%) 
 
Currently consumes alcohol 
Yes       (N = 48, 57.1%) 
No       (N = 36, 42.9%) 






















Psychiatric History Interview Duration 
1 Ellen Female 60 57 Divorced Retired No 65 minutes and 28 
seconds 
2 Pat Male 84 78 Married Retired No 60 minutes and 43 
seconds 
3 Kate Female 72 70 Married Unemployed No 60 minutes and 19 
seconds 
4 Joe Male 72 70 Unmarried Retired No 70 minutes and 30 
seconds 
5 James Male 70 60 Divorced Retired No 71 minutes and 53 
seconds 
6 Anne Female 60 59 Widowed Employed No 48 minutes and 25 
seconds 
7 Daniel  Male 71 68 Married Retired No 44 minutes and 16 
seconds 
8 Peter Male 76 74 Married Retired No 49 minutes and 12 
seconds 
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9 Robert  Male 61 56 Widowed Retired  No 45 minutes and 30 
seconds 







3.6: Procedure  
3.6.1: Data collection 
The quantitative and qualitative procedures are outlined. 
 
3.6.2: Quantitative Procedure: 
For the first part of the study, patients who had read the information sheet and 
provided written informed consent were provided with a questionnaire booklet to complete. 
Participants completed four questionnaires in the out-patient clinic. Completion of the 
questionnaires took approximately ten to twenty minutes. In instances where it was preferable 
for participants to complete the questionnaires at home, they were provided with a stamped 
addressed envelope. Research assistants remained at the clinic to answer any questions and 
re-iterate information about participant rights and confidentiality. 
 
3.6.3: Qualitative Procedure: 
Patients who fulfilled the study criteria were recruited as per details in section 3.5.3. 
The interviews took place in the hospital. Prior to each interview, patients were given another 
copy of the information sheet and consent form. Verbal informed consent was requested. The 
patients were reminded of confidentiality and their rights. An overview of the interview was 
provided. Participants were invited to ask questions about participation. Consent to record the 
interview was sought from each participant. The interviews were carried out in a relaxed and 
conversational manner to allow the opportunity for the participant to feel comfortable, reflect 
and expand on their points to give insight into their personal experiences. At the end of the 
interview, all participants were thanked for their contribution and verbally debriefed. They 
were offered the opportunity to ask any additional questions. The researcher informed 
patients about available psychological supports in the hospital and the referral pathway was 
detailed for them. Participants were asked to contact the researcher if further support was 
required. Where further support was indicated, the researcher then made contact with the 
psychologist in the psycho-oncology department and the participant was offered support.  
 
3.7: Measures used in Quantitative and Qualitative Research 
3.7.1: Demographics: 
 A bespoke instrument was designed to collect demographic information including; 
age, age at diagnosis, gender, occupational status, living arrangements, level of education, 
mental health history, smoking status and weekly alcohol consumption (see Appendix C).  
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3.7.2: Brief Illness Perceptions Questionnaire (Brief IPQ):  
Illness perceptions were measured using the Brief IPQ (Broadbent et al., 2006). It is a 
nine item self-report measure (see Appendix D). The first eight items are rated on a Likert 
scale from zero to ten and measures both cognitive and emotional perceptions of illness 
(Broadbent et al., 2006). The final question is an open ended question which asks the 
participant to list the three most important factors they believed to have caused their illness 
(Broadbent et al., 2006). Scoring on the Brief IPQ subscales range from zero to ten. Higher 
scores on the Consequences, Timeline, Identity, Concern and Emotional Representations 
subscales reflect more negative illness perceptions. While lower scores on the Control and 
Coherence subscales indicate more negative illness perceptions. This Brief IPQ has been 
utilised in diverse populations of patients with a range of illnesses and across various age 
ranges. As indicated earlier, the Brief IPQ has good test-retest reliability (α = .6 - .8), 
concurrent (r = .17 - .49), predictive and discriminant validity (Broadbent et al., 2015).  
 
3.7.3: Hospital Anxiety and Depression Scale (HADS):  
Emotional distress was measured using the HADS (Zigmond & Smith, 1983). A copy 
of the HADS was not included in the appendices due to copyright issues. A license 
agreement was completed in order for it to be utilised in this study, however a copy of the 
HADS cannot be reproduced in a thesis appendices (Snaith, 2003). It is a fourteen item self-
report measure which was developed in order to assess anxiety and depression in patients 
with a physical illness. There are two subscales which include seven items to measure anxiety 
and depression on each scale. All items are rated on a Likert Scale from zero to three (‘0’ not 
at all to ‘3’ nearly all the time). Therefore, scores range from zero to twenty-one on each 
subscale. Scores ranging from ‘0-7’ are considered to be below the threshold for 
anxiety/depression, those in the ‘8-10’ range are considered to be in the mild range of 
symptoms, those in the ‘11-14’ range, moderate and those in the ‘15-21’ range are considered 
to be within the high/severe range of symptoms. The HADS has good psychometric 
properties including good reliability (α = .79 - .87) (Bjelland, Dahl, Haug, & Neckelmann, 
2002). Djukanovic, Carlsson, and Årestedt (2017) demonstrated validity for the HADS by 
confirming the two-factor structure and internal consistency of the measure. It is frequently 
used in cancer patient populations, particularly for the screening of psychological distress 
(Mitchell, Meader, & Symonds, 2010).  
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3.7.4: The Carver Brief Coping Orientation to Problems Experienced (Brief 
COPE): 
Coping is defined as the cognitive and behavioural strategies employed to manage 
stress (Folkman & Moskowitz, 2004). Coping responses were measured using the Brief 
COPE (Carver, 1997) (see Appendix E). This is an abbreviated version of the COPE 
encompassing a twenty-eight item self-report measure. With less questions to answer, it was 
designed to reduce the burden on participants (Carver, 1997). Each statement is rated on a 
four point Likert Scale from one (I haven’t been doing this at all) to four (I’ve been doing this 
a lot) (Carver, 1997). A higher score on a dimension indicates greater use of a particular 
coping strategy. There are fourteen dimensions of coping strategies in the scale which 
comprise of: active, denial, utilisation of emotional support and instrumental support, 
venting, behaviour disengagement, positive thought reframing, planning, acceptance, 
humour, blaming the self, religion and substance abuse (Carver, 1997). Scores range from 
two to eight. It has been found to have appropriate psychometric properties with respect to 
reliability (α = .68 - .89) and validity (internal consistency range .051 - .099) (Yusoff, Low, 
& Yip, 2010).  
A review of the COPE Inventory conceptualised that strategies cluster together into 
two categories: approach and avoidant coping (Litman, 2006) and are frequently categorised 
in the literature (e.g., Boden, Bonn-Miller, Vujanovic, & Drescher, 2012; Green, Wells, & 
Laakso, 2011; Taylor et al., 2015; van Montfort et al., 2020). Approach coping refers to 
strategies employed that are targeted at the threat (e.g., planning) and avoidant coping refers 
to strategies that are redirected away from the threat (e.g., denial). In this study, two 
subscales of approach and avoidant coping were calculated. Approach coping was calculated 
from a mean score from the active, planning, positive reframing, acceptance and use of 
emotional and instrumental support construct dimensions. Avoidant coping was calculated 
from a mean score from the humour, religion, self-distraction, denial, venting, substance 
abuse, behavioural disengagement and self-blame construct dimensions. Approach and 
avoidant coping subscales have demonstrated acceptable reliability (α = .86, α = .71 
respectively) in the literature (Taylor et al., 2015).  
 
3.7.5: Interview Schedule for the Qualitative Research  
A research protocol and interview schedule (see Appendix F) were created for the 
study. The interviews were semi-structured and were considered appropriate for this piece of 
research in order to gain an in-depth account of each patient’s personal experience (Smith et 
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al., 2009). Interviews are a helpful way of allowing participants to explain the meaning of 
their point of view (Willig, 2008). An interview guide was developed by the researcher. It 
was developed by reviewing the available literature, making use of research supervision and 
reflecting on feedback. The interview schedule contained open-ended questions and prompts. 
While it was a very useful guide, it was not followed in a prescriptive manner.  
Following consent from the participants, all interviews were audio recorded using a 
dictaphone. Each interview was transcribed verbatim which included all utterances and 
sounds. Transcripts were reviewed by the researcher to ensure accuracy. The length of the 
interviews ranged from 43 minutes and 31 seconds to 71 minutes and 53 seconds (M = 55 
minutes and 58 seconds). The total duration of all interviews was 9 hours and 33 minutes. 
See Table 2 for further details. The researcher analysed each of the ten transcripts.  
The researcher engaged in reflection during the course of the study. For example, the 
researcher wrote in a reflective diary after each interview was conducted, during 
transcription, during the data analysis phase and following research supervision. See 
Appendix H for extracts from the reflective diary.  
 
3.8: Data analysis 
3.8.1: Quantitative Data Analysis: 
A priori power analysis was carried out using the G*power 3.1 software, to establish 
adequate sample size (Faul, Erdfelder, Buchner, & Lang, 2009). For the main outcome 
measure of psychological distress which comprised of two dependent variables (anxiety and 
depression) and predictor variables (ten subscales: eight illness perceptions subscales and two 
Brief COPE subscales), a power estimate of .95, effect size f2 = .35 (large effect size), an 
alpha error probability of .05, the sample size advised for a Linear multiple regression 
analysis was computed as N = 80. 
Participants were assigned a participant number at the data collection phase, and thus 
it was anonymised at source. The data was then scored and inputted in to a password 
protected file on a database using the IBM statistics Package for the Social Sciences Version 
23 (SPSS – 23). The data was examined for missing responses. Missing data was dealt with 
case-wise. 
Descriptive statistics provided detailed information about the population. Descriptive 
statistics were employed to summarise and describe observable patterns across the data, for 
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example, age, number of years since diagnosis, gender, and occupational status. Refer to 
Table 1 for details.  
Statistical analysis was carried out at the < .05 alpha level of statistical significance. 
All statistical tests were two-tailed. The assumptions of all parametric tests were checked and 
met, unless reported otherwise. In such cases, suitable non-parametric tests were carried out. 
Linearity, normality and equality of variances were analysed by visual inspection of 
scatterplot graphs, Q-Q plots and Skewness/Kurtosis to ensure assumptions were met.    
In order to test the hypotheses and examine associations between the predictor 
variables (illness perceptions and coping strategies) and dependent variables (anxiety and 
depression), tests of correlations, t-tests, ANOVA’s and multiple regression analysis were 
employed. Entry criterion for the multiple regression comprised of variables that were 
significantly correlated (p < .05) with the dependent variables. In instances where the 
assumption of equality of variance was not met by Levene’s test, the Welch F-ratio was 
reported.  
Regarding effect sizes, the strength of association to particular values was calculated 
as Cohen’s d, where (0.2 - 0.49) was considered a small effect size, (0.5 - 0.79) a medium 
and (>0.8) a large effect size (Cohen, 1988). Eta squared (η2 ) was calculated where .01 was a 
small effect size, .06 medium and .14 a large effect size. 
Internal consistency reliability tests were carried out for each scale and demonstrated 
acceptable internal consistency for all scales except the Avoidant Coping subscale. A 
reliability test was not conducted on the Brief IPQ because each construct/item was assessed 
with one question. Items within the Brief IPQ represent divergent beliefs and do not 
constitute an overarching construct. Table 3 below details the Cronbach’s Alpha levels for 
the scales in the current study. 
 
Table 3 
Cronbach’s Alpha scores for relevant scales in the current study 
Scale       Cronbach’s Alpha Level 
 
HADS       α = .85 
HADS (Anxiety Subscale)    α = .84 
HADS (Depression Subscale)   α = .76 
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Brief COPE       
Approach coping     α = .77 
Avoidant coping     α = .55 
 
 
3.8.2: Qualitative Data Analysis: 
Each transcript was analysed using the IPA framework. This process is described in 
Smith and colleagues (2009) and was followed by the researcher. During the first step of 
analysis, the researcher became deeply familiar with the data by reading the transcripts 
several times. The researcher listened to the audio recordings numerous times to get a sense 
of the patients tone of voice, humour, sarcasm and other aspects of speech that cannot easily 
be determined from written transcripts. Once the researcher became very familiar with the 
transcripts, the second step of the IPA analytic process for each participant was undertaken 
by the initial coding of the data. Each transcript was separated into three columns with the 
transcript in the middle column (Smith et al., 2009). Possible themes were noted in the 
column on the left. The margin on the right was used for reflection and exploratory 
comments. Step three of the analytic process involved interpretive coding of the exploratory 
comments including descriptive notes that summarised a point, conceptual notes that made 
inferences and interpretations about the content within the data and linguistic notes about the 
way language was utilised by the participant (Smith et al., 2009). Please refer to Appendix G 
for an example of this process. Smith et al. (2009) documented that linguistic, conceptual and 
descriptive comments should be italicised, underlined and unformatted in that order. In step 
four, emergent themes were developed at the individual transcript level. During step five, the 
researcher followed the first four steps for each transcript and identified patterns across 
participants into categories of subordinate themes. The final step encompassed the detection 
of superordinate themes. This involved creating a table of all themes generated from all the 
transcripts and configuring similarities and differences between themes. This allowed for the 
identification of superordinate themes by considering the data as a whole.  
 
3.9: Ensuring Quality in IPA Methodology 
 Research trustworthiness and credibility in IPA research is centred around four 
criteria: sensitivity to context, commitment and rigour, transparency and coherence and 
impact and importance. 
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 3.9.1: Sensitivity to Context 
 The researcher took care to establish sensitivity to context by conducting a thorough 
and critical review of the existing literature. This allowed the researcher to become familiar 
with the literature base and the burden the population of participants had to manage. 
Regarding the socio-economic and cultural context of the research population, the author 
took time to recognise and acknowledge differences between the researcher and the 
participants. During each interview, the researcher displayed empathy and placed the patients 
at ease in order to manage any differences. Furthermore, the researcher was not an employee 
in the hospital where the research took place and thus was not involved in patient care. 
Participants were explicitly told this and it was helpful in ameliorating power differences. 
During analysis, the researcher took significant care to stay close to the data and 
contextualise it during the write up of the results. 
 
3.9.2: Commitment and Rigour  
Commitment to the research was achieved through close engagement with the data 
during collection and analysis. The author drew upon her understanding of the challenges of 
cancer which supported her ability to demonstrate empathy towards the participants and 
generate meaningful data. It was acknowledged that the researcher was a novice with IPA 
methodology. Therefore, the researcher read extensively about how to conduct IPA research, 
used supervision and attended IPA workshops. During interviews and analysis, the author 
listened very closely to the words of the patients in order to be able to be rigorous during data 
analysis. 
 
3.9.3: Transparency and Coherence  
Transparency was attained by giving a complete account of the way in which the 
methodology and analysis were conducted. This results section includes verbatim extracts 
from the transcripts. As outlined, the appendices section contains information and examples 
of how themes were developed (see Appendix G). The researcher used supervision to ensure 
coherence in the way in which the data was analysed and presented. The researcher kept a 
reflective journal in order to make sense of the research process thus aiding coherence.  
 
3.9.4: Impact and Importance 
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 With respect to impact and importance, it is clear that the findings of the study 
contribute to both the theoretical model, SRM, and clinical practice. The study has significant 
implications for practitioners in terms of their understanding of NMIBC patients illness 
perceptions, coping and psychological well-being. It is hoped this knowledge will serve to 
support service planning and provision as well as the development of psychological 
interventions to reduce psychological distress in the population. 
 
3.9.5: Reflexivity 
 Reflexivity refers to the way in which the researcher reflected on their personal 
influence on the research. The researcher acknowledged her role in the study. Personal 
experiences, thoughts, beliefs and perceptions of the researcher about BC, the research and 
the participants were considered. For this reason, a reflective journal was kept throughout the 
research process which was helpful in making sense of the impact of these factors on the 
study (see Appendix H). 
 
3.10: Ethical Considerations 
 This study received ethical approval from the clinical research ethics committee of the 
Cork Teaching Hospitals (see Appendix J). 
 All participants gave informed consent to take part in the study via verbal and written 
consent. The detailed information sheet and consent form provided participants with key 
information about what was involved in participation. Research assistants, under the direct 
supervision of a Principal Clinical Psychologist, were available to answer any questions in 
order to ensure that consent was informed. No deception or withholding of information was 
used in the study. As a safeguarding measure, participants were reminded about their rights to 
withdraw from the study and that it would have no impact on the service that they receive. In 
a further attempt to manage safeguarding, the research assistants acted as gate keepers for the 
qualitative part of the research. This was to ensure the integrity of the informed consent 
process for taking part in the interview.  
 Regarding confidentiality and anonymity, participants in the quantitative group were 
assigned a participant number and their data was anonymised at source. Hard copies of the 
quantitative data were stored in a locked filing cabinet in a locked office in the Department of 
Clinical Psychology in the hospital. Participants in the qualitative group were given a 
pseudonym and the main researcher was the only individual who had access to the 
pseudonym-coding document. Quantitative data, audio files of the interviews and transcripts 
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were stored on an encrypted, password protected USB key and only the research team were 
given access. With respect to the interviews, identifying information was taken out of the 
transcripts. Finally, limits to confidentiality were described in the information sheet and 
consent form and discussed with participants. 
 Potential distress from participation was considered. All participants were verbally 
debriefed following completion of participation. In the event of distress, participants were 
informed about available support. Participants were advised about and assisted with a referral 
pathway to the clinical psychology service attached to the Urology Department if required.  
 
3.11: Conclusion 
 To conclude, the methodology chapter presented a rationale for the mixed methods 
research design. Furthermore, it provided an account of the research and analysis procedures. 






















Chapter 4. Results 
4.1: Chapter Overview  
This chapter is divided into two parts: quantitative findings and qualitative findings.  
  
4.1.1: Quantitative Results Overview 
A description of the descriptive and inferential statistics used to investigate the 
hypothesis are outlined. Descriptive statistics for the mean scores regarding each of the 
variables are detailed. Correlational analyses, a series of independent t-tests and one-way 
ANOVA’s were performed and described to better understand the relationships among the 
variables. Lastly, regression analyses are presented to examine the proposed predictive model 
of illness perceptions and coping on psychological distress.  
 
4.2: Descriptive Statistics 
4.2.1: Brief IPQ 
 The total sample mean score for each construct on the Brief IPQ was calculated. 
Table 4 below details the scores. Higher scores on the Consequences, Timeline, Identity, 
Concern and Emotional Representations indicate more negative illness perceptions. Timeline, 
Concern and Emotional Representations all had a mean score over 5. Lower scores on the 
Control and Coherence constructs indicate more negative illness perceptions. Personal 
Control had a mean score of less than 5.   
 
Table 4 
Brief IPQ. Sample Means and Standard Deviations 
 
      M   SD  Range 
Illness Perceptions (Brief IPQ):       0-10 (all) 
 
Consequences     3.52   2.95   
Timeline     6.37   3.71   
Control (Personal)    4.94   3.9   
Control (Treatment)    8.63   2.17 
Identity     2.62   2.62 
Concern     5.02   3.48 
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Coherence     7.42   2.67 
Emotional Representations   6.37   3.71 
 
4.2.2: Brief COPE 
 The total mean score for Approach Coping and Avoidant Coping was calculated. 




Brief COPE. Sample Means and Standard Deviations 
 
      M   SD  Range 
Brief Cope           
 
Approach Coping    28.12   8.4  12-48 
Avoidant Coping    25.29   6.19  16-64 
 
 
 4.2.3: HADS 
 The total mean score was calculated for each of the subscales. Higher scores reflect 
greater distress. The mean score on the anxiety and depression subscales fell below the 
threshold of distress (<8). Table 6 below details the mean scores.  
On further inspection, a chi-square goodness-of-fit test was conducted to determine 
the frequency of the symptom levels of depression and anxiety. The chi-square goodness-of-
fit test indicated that the number of participants reporting minimal, mild, moderate and severe 
symptoms of depression was statistically significantly different (χ2 (12) = 47.05, p < .001) 
indicating that the frequency of scores was not evenly distributed. The results showed that 
15.8% of participants were above the cut-off score of 8, indicating presence of depressive 
symptoms. Within the sample, 10.9% reported mild symptoms of depression, 3.6% moderate 
symptoms and 1.2% severe symptoms of depression.  
The chi-square goodness-of-fit test indicated that the number of participants reporting 
minimal, mild, moderate and severe symptoms of anxiety was not statistically significantly 
different (χ2 (17) = 25.00, p > .05) indicating that the scores were relatively evenly 
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distributed. The results showed that 38.3% of participants were above the cut-off score of 8, 
indicating presence of anxiety symptoms. Within the sample, 23.4% reported mild symptoms 
of anxiety, 11.1% moderate symptoms and 4.9% severe symptoms of anxiety. 
 
Table 6 
HADS. Sample Means and Standard Deviations 
 
     M  SD  Range 
HADS: 
Anxiety    6.58  4.19  0-21 
Depression    3.79  3.52  0-21. 
Note: for the Anxiety and Depression subscales, scores in the 0-7 range are considered to be 
below the threshold for anxiety/depression, the 8-10 range are considered mild symptoms, the 
11-14 range moderate and the 15-21 range high/severe symptoms. 
 
4.3: Demographic Factors and their Relationships to Illness Perceptions, Coping and 
Psychological Distress 
 A Pearson Product-Moment Correlation Coefficient was performed to better 
understand the relationships of the demographic variables to illness perceptions, coping and 
psychological distress. No formal hypotheses were stated for these relationships. The 
assumption of linearity was met for all variables. The Shapiro-Wilk’s test indicated that not 
all variables were normally distributed (p < .05). However, given that such tests of normality 
may be overly conservative, a visual inspection of Q-Q plots demonstrated that the 
assumption of normality was met for all variables. 
 A series of independent t-tests and one-way ANOVA’s were carried out on variables 
measured at the nominal level (type of treatment, gender, marital status, employment status, 
current smoking use and history of psychiatric problems) to better understand their 
relationship to the DV’s. No formal hypotheses were stated for these relationships. All 
assumptions were met unless otherwise stated. 
 
 4.3.1: Age 
 Age was not associated with approach coping (r(82) = -.17, p = .12), avoidant coping 
(r(82) = .16, p = .15) anxiety (r(80) = .03, p = .77) or depression (r(81) = 1.12, p = .27). 
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 4.3.2: Number of Years Since Diagnosis 
 Number of years since diagnosis was found to be positively correlated with avoidant 
coping (r(80) = .30, p .= .01). It was not associated with approach coping (r(82) = .11, p = 
.31), anxiety (r(79) = .09, p = .41) or depression (r(79) = .09, p = .41). 
 
 4.3.3: Type of Treatment 
 An independent samples t-test found no main effect of type of treatment on 
depression scores (t(80) = -1.352, p = .18). Levene’s test confirmed that the assumption 
homogeneity of variance was met (F(80) = .119, p = .73). 
Furthermore, an independent samples t-test found no main effect of type of treatment 
on anxiety scores (t(79) = -.289, p = .77). Levene’s test confirmed that the assumption 
homogeneity of variance was met (F(79) = .518, p = .47). 
 
4.3.4: Gender 
 Males reported slightly higher depression scores (M = 3.27, SD = 3.41) than females 
(M = 4.04, SD = 3.75). Levene’s test confirmed that the assumption homogeneity of variance 
was met (F(80) = 0.37, p = .85). An independent samples t-test found no main effect of 
gender on depression scores (t(80) = .918, p = .36). 
 Females reported higher anxiety scores (M = 8.44, SD = 3.90) than males (M = 5.75, 
SD = 4.08). The mean score of males did not reach the threshold for a clinical level of anxiety 
while the mean score for females fell in the mild range. Levene’s test confirmed that the 
assumption homogeneity of variance was met (F(79) = .203, p = .65). An independent 
samples t-test found no main effect of gender on anxiety scores (t(79) = -2.778, p = .007). 
 
 4.3.5: History of Psychiatric Problems 
 Participants who reported a history of psychiatric problems reported higher 
depression scores (M = 6.63, SD = 6.23) than those who reported no history (M = 3.34, SD =  
2.75) although both scores fell below the threshold for depression. Levene’s test indicated 
that the assumption homogeneity of variance was violated (F(79) = 24.437, p = <.001) 
therefore, Welch’s F-ratio is reported. An independent samples t-test found no main effect of 
history of psychiatric problems on depression scores (t(7.30) = 1.474, p = .18). 
 Participants that reported a history of psychiatric problems reported higher anxiety 
scores (M = 7.43, SD = 5.00) than those who reported no history (M = 6.36, SD = 3.98) and 
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again both scores fell below the threshold for anxiety. Levene’s test confirmed that the 
assumption homogeneity of variance was met (F(78) = .478, p = .48). An independent 
samples t-test found no main effect of history of psychiatric problems on anxiety scores 
(t(78) = .667, p = .51). 
 
4.3.6: Current smokers  
 Participants who reported that they are currently smoking had higher depression 
scores (M = 4.37, SD = 4.86) than those who reported that they are not smoking (M = 3.68, 
SD =  3.21) although both scores fell below the threshold for depression. Levene’s test 
indicated homogeneity of variance (F(80) = .19, p = .19). An independent samples t-test 
found no main effect of current smoking use on depression scores (t(80) = .657, p = .51). 
 Participants who reported that they are currently smoking reported higher anxiety 
scores (M = 8.07, SD = 4.34) than those who reported that they are not currently smoking (M 
= 6.27, SD =  4.13) with smokers falling in the mild range of anxiety. Levene’s test 
confirmed homogeneity of variance (F(79) = .00, p = .99). An independent samples t-test 
found no main effect of smoking on anxiety scores (t(79) = 1.474, p = .14). 
 
 4.3.7: Marital Status 
 A series of one-way ANOVA’s with anxiety and depression scores as the dependent 
variables and marital status as a fixed-factor was performed. The Levene’s statistic indicated 
the homogeneity of variance assumption was violated for depression (F(3, 78) = 4.63, p = 
.005) and therefore Welch’s F-ratio is reported. Homogeneity of variance was met for anxiety 
(F(3, 77) = .02, p = .99). No significant effect of marital status on depression (F(3, 22.47) = 
2.47, p = .09) or anxiety (F(3, 77) = 1.73, p = .17) was found. Post-hoc analysis revealed no 
significant differences between groups. 
 
 4.3.8: Employment Status 
 A series of one-way ANOVA’s with anxiety and depression scores as the dependent 
variables and employment status as a fixed-factor was performed. The Levene’s statistic 
indicated homogeneity of variance for depression (F(2, 78) = .90, p = .41) and anxiety (F(2, 
77) = 1.97, p = .15). No significant effect of employment status on depression (F(2, 78) = .59, 
p = .56) and anxiety (F(2, 77) = .01, p = .99) was found. Post-hoc analysis revealed no 
significant differences between groups. 
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4.4: Relationships between Illness Perceptions, Coping and Psychological Distress 
A Pearson Product-Moment Correlation Coefficient was performed to better 
understand the relationships between illness perceptions, coping and psychological distress. It 
was hypothesised that more negative perceptions of NMIBC would be associated with higher 
levels of psychological distress; use of avoidance-based coping strategies would be 
associated with higher levels of psychological distress and; use of approach-based coping 
strategies would be associated with lower levels of psychological distress. The assumption of 
linearity was met for all variables. The Shapiro-Wilk’s test indicated that not all variables 
were normally distributed (p < .05). However, visual inspection of Q-Q plots demonstrated 
that the assumption of normality was met for all variables. 
 
 4.4.1: Illness Perceptions 
 Higher scores on the Consequences construct was positively associated with higher 
levels of anxiety (r(80) = .44 p < .001) and depression (r(81) = .33, p = .003). Timeline was 
not associated with depression (p = .11), although higher Timeline scores were associated 
with greater levels of anxiety (r(80) = .33, p = .003). Higher Identity scores were found to be 
positively associated with higher levels of anxiety (r(80) = .26 p = .02) and depression (r(80) 
= .3, p = .006). NMIBC patients who reported higher scores on the Concern construct had 
greater levels of anxiety (r(80) = .45 p < .001), although it was not associated with depression 
(p = .16). Higher scores on the Emotional Representations construct was positively associated 
with higher levels of anxiety (r(80) = .64 p < .001) and depression (r(80) = .38, p < .001). 
Personal Control was not associated with anxiety (p = .62) or depression (p = .38). Treatment 
Control was not associated with anxiety (p = .53) or depression (p = .78). Coherence was not 
associated with anxiety (p = .16) or depression (p = .39). Participants who had stronger 
beliefs about the Consequences, Timeline, Identity, Concern and Emotional Representations 
of NMIBC were more likely to report greater anxiety scores. Additionally, patients who had 
stronger beliefs about the Consequences, Identity and Emotional Representations of NMIBC 
were more likely to report greater depression scores. Table 7 below details the findings. 
 
4.4.2: Coping 
 Approach coping was not associated with anxiety (p = .06) or depression (p = .85). 
Patients with NMIBC who reported higher avoidant coping scores were positively associated 
with greater levels of anxiety (r(80) = .57, p < .001) and depression (r(80) = .43, p < .001). 
As predicted, use of avoidance-based coping strategies was found to be associated with 
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higher levels of psychological distress. However, use of approach-based coping strategies 




Correlations between illness perceptions, coping and psychological distress. 
 
      Anxiety  Depression 
 
Illness Perceptions: 
Consequences     .44**   .33** 
Timeline     .33**   .18 
Personal Control    -.06   -.10 
Treatment Control    -.03   -.07 
Identity     .26*   .3** 
Concern     .45**   .16 
Coherence     -.10   -.16 
Emotional Representations    .64**   .38** 
 
Coping: 
Approach Coping    .22   -.02 
Avoidant Coping    .57**   .43** 
Note: * p < .05, ** p < .005 
 
4.5: The Predictive Value of Illness Perceptions and Coping to Psychological Distress 
 Two hierarchical stepwise regressions analyses were conducted in order to determine 
the influence of illness perceptions and coping on psychological distress (anxiety and 
depression). Illness perceptions were entered into the first step and coping into the second 
step of the model, in line with the SRM. All demographic variables were removed from 
analysis because the variables did not meet entry criteria for the regression analysis as they 
were not found to be associated with the DV’s (p = > .05). Only variables that were found to 
significantly (p = < .05) correlate with the DV’S were entered in to the regression analysis. 
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Non-significant illness perceptions and coping strategies were removed accordingly, in line 
with previous research (e.g., Cartwright, Endean, & Porter, 2009; Evans & Norman, 2009). 
The assumption of linearity was met for all variables. Visual inspection of Q-Q plots 
demonstrated that the assumption of normality was met for all variables. The assumption of 
independence of residuals was met by a Durbin-Watson statistic of 2.40 (depression model) 
and a statistic of 1.98 (anxiety model). Homoscedasticity was met and observed via visual 
inspection of a plot of studentised residuals versus unstandardized predicted values. The 
assumption of multicollinearity was met for all variables as tolerance values greater than 0.1 
and reciprocal VIF values less than 10 were observed for all variables. No significant outliers 
were detected.  
 
4.5.1: Depression Model 
A hierarchical linear regression was conducted to examine whether illness perceptions 
significantly predicted depression when controlling for coping. 
Illness perception constructs that were found to be associated with depression were 
entered into the first step of the model (Consequences, Identity and Emotional 
Representations) followed by significantly correlated coping strategies (Avoidant Coping) in 
the second step. The Enter method was used in all three blocks.  
The first block, with illness perception variables as predictors was significant, F(3,77) 
= 6.12, p = .001, adjusted R2 = .161. Illness perceptions accounted for 16.1% of the variance 
in depression. The second block with coping variables as predictors was also significant 
F(1,76) = 5.30 p = .02, adjusted R2 = .205. The addition of coping in the second step lead to a 
significant change in the model with an additional 4.4% of the variance in depression being 
explained. The full model of illness perceptions, while controlling for coping in order to 
predict depression (Model 2) was statistically significant R2 = .245, F(4,76) = 6.16, p = < 
.001, adjusted R2 = .205. 
 Examination of Table 8 confirmed that when controlling for coping variables only the 
illness perception variable Emotional Representations significantly predicted depression (p = 
.04). Greater Avoidant Coping scores predicted higher levels of depression (p = .02).  
Regarding the hypothesis, it was found that only stronger perceptions of Emotional 
Representations in NMIBC predicted greater levels of depression. 
 
Table 8 
Hierarchical multiple regression of depression with final block (predictors) 
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       Standard Error 
     B  B   Beta 
 
Block 2     
Constant     -1.60  1.54 
Consequences    -.03  .18   -.02      
Identity    .14  .18   .10       
Emotional Representations  .28  .13   .26* 
Avoidant Coping   .16  .07   .28*   
 
Note 1: Criterion variable: Depression 
Note 2: * Variable significantly adds to the model 
 
4.5.2: Anxiety Model 
A hierarchical linear regression was conducted to examine whether illness perceptions 
significantly predicted anxiety when controlling for coping. 
Illness perception constructs that were found to be associated with anxiety were 
entered in to the first step of the model (Consequences, Timeline, Identity, Concern and 
Emotional Representations) followed by significantly correlated coping strategies (Avoidant 
Coping) in the second step. The Enter method was used in all three blocks.  
The first block, with illness perception variables as predictors was significant, F(5,73) 
= 14.16, p = < .001, adjusted R2 = .492. Illness perceptions accounted for 49.2% of the 
variance in anxiety. The second block with coping variables as predictors was also significant 
F(1,72) = 15.38 p = < .001, adjusted R2 = .547. The addition of coping in the second step lead 
to a significant change in the model with an additional 5.5% of the variance in anxiety being 
explained. The full model of illness perceptions, while controlling for coping strategies in 
order to predict anxiety (Model 2) was statistically significant R2 = .582, F(6,72) = 16.69, p = 
< .001, adjusted R2 = .547. 
 Examination of Table 9 confirmed that when controlling for coping variables only the 
illness perceptions variables Timeline and Emotional Representations significantly predicted 
anxiety (p = .002, p = < .001) respectively. Greater Avoidant Coping scores predicted higher 
levels of anxiety (p = < .001). Regarding the hypothesis, it was found that only stronger 
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Hierarchical multiple regression of anxiety with final block (predictors) 
 
       Standard Error 
     B  B   Beta 
 
Block 3     
Constant     -3.80  1.55 
Consequences    -.02  .17   -.02     
Timeline    .29  .09   .26*       
Identity    -.10  .17   -.06      
Concern    -.04  .15   -.03    
Emotional Representations  .65  .17   .50*   
Avoidant Coping   .26  .07   .38*  
 
Note 1: Criterion variable: Anxiety 
Note 2: * Variable significantly adds to the model 
4.6: Qualitative Results Overview  
 The researcher engaged in a prolonged period of familiarisation with the data, which 
comprised of transcription of the interviews, multiple readings, analysis and collation. 
Following this process, a number of superordinate and subordinate themes developed from 
the data. The purpose of this chapter was to communicate a coherent summary of the results 
which emerged from the interviews of all ten participants. Thus, all three superordinate and 
subordinate themes are presented, described and interpreted. Table 10 below provides an 
outline of the superordinate and subordinate themes.  
Direct quotes are interwoven into the results as a means of providing insight into the 
lived experience of the participants. Analytical comments serve as the researchers 
interpretation of the themes. Quotes are presented italicised in the centre of the page. 
Sequences of the three dots represents a significant pause, while the notation [] represents the 
removal of irrelevant text. The use of brackets is included to provide explanatory information 
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to help the reader better understand the context and meaning of the words of the participant. 
In order to protect the anonymity of health care providers and significant others of the 
participants, secondary identifiers including gender pronouns and descriptions about previous 
or current health problems have been removed. 
Finally, this part of the results chapter encompassed a number of reflective memo 
boxes interspersed at significant points of analysis. The purpose of this was to give additional 
insight into the way in which the researcher engaged in reflection during the research process. 
Table 10 
Superordinate and subordinate themes 
 
Superordinate Theme    Subordinate theme 
1. Making Sense of NMIBC    Diagnosis 
       NMBIC as a physical entity 
 
 
2. The Dynamic Nature of Illness Perceptions Illness identity 
       Control 
 
 
3. Coping      Isolation 
       Cognitive appraisal 
       Emotion-focused coping 
 
4.7: Overview of the Superordinate Themes 
 Interpretation of the qualitative data was derived from the accounts of the participants. 
The first theme ‘Making Sense of NMIBC’ relates to participants’ experiences of deriving 
understanding and meaning about their illness. Experiences of diagnosis supported patients in 
making meaning of NMIBC. It became clear that NMIBC was conceptualised as a physical 
entity. Therefore, the physical impacts of NMIBC are delineated while disconnection from 
the emotional aspects of the illness are interpreted. 
 The second theme relates to the ever changing nature of illness perceptions. 
Participants’ personal experiences were internalised and subsequently shaped their illness 
identity. This theme additionally highlights the influence of the doctor-patient relationship on 
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control representations of NMIBC. Key events and interpersonal experiences that molded 
perceptions are delineated. 
 Finally, the theme of coping elicits participants’ narratives of managing their illness 
and challenging emotions. Themes of isolation, cognitive appraisal and emotion-focused 
coping permeated throughout this process. Participants managed difficult emotions in order 
to remain resilient and stoic. 
Participants’ lived experiences of their illness perceptions are considered in dynamic 
terms. This means that beliefs, emotional representations and selection of coping strategies 
are continually being appraised and amended throughout the illness journey.  
 
Reflective Box: 
Conducting the interviews was a very humbling experience. For me, the interviews 
provided the opportunity to listen to the experiences of the patients and capture their 
insights. I found myself frequently referring to Yardley’s criteria outlined in Smith and 
colleagues (2009), particularly sensitivity to context to ensure validity. I learned that 
grounding myself in empathy and the use of semi-structured interviews offered space for 
deeper reflection and ultimately richer data. 
Analysis of the data proved both a difficult and rewarding task. I found IPA to be a good 
match for exploring experiences of NMIBC and the SRM a useful framework for 
understanding patients’ perspectives and beliefs about their illness. Use of supervision and 
a reflective journal supported my ability to remain flexible and open-minded during the 
analysis stage. Ultimately, trusting in the data was crucial to representing the words of the 
participants.   
 
4.8: Theme 1: Making Sense of NMIBC 
 Participants spoke at length about the significance of diagnosis in making sense of 
their disease. This theme illustrated that it was a key moment in understanding the illness in 
practical terms. Conceptualisation of NMIBC was understood as a physical entity. While 
each person’s experience was different, lack of insight regarding the emotional aspects of the 
illness was common among participants. 
 
 4.8.1: Diagnosis 
All participants described their experience of receiving their diagnosis of NMIBC. At 
the beginning of the accounts, participants frequently focused on describing their 
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experiences, in terms of timeline and practicalities, with little mention of the psychological 
aspects of the experience. Daniel described his experience of being referred by his GP to the 
hospital and the process of being diagnosed. His story is told in an indifferent, neutral manner 
without reference to any possible emotional impacts of being told that he had cancer. 
 
‘He referred me, yeah. And em… That was it really, from there (the doctor) saw me, 
and I had a cystoscopy and eh… they found a …. What is- what do you call it?  
Tumour or growth or whatever’ (Daniel) 
 
Similarly, Peter’s account focused on the timeline and medical aspects of his 
diagnosis. He described a process of being on surveillance until he received his diagnosis.  
 
‘Well the treatment was eh… Cystoscopy first, and there was an on-going three 
months of checking. And em… It’s hard then to think now… Well eventually they 
found a growth,  eh… which they said was low level cancer, and that they would 
remove it, which they did.’ (Peter) 
 
 Both descriptions are benign in nature and illustrate that both individuals did not 
display close identification with the disease, with Peter describing it as ‘low level’ and Daniel 
as a ‘tumour, growth or whatever’. This indicates that their perception of NMIBC is of minor 
concern and one that has minimal impact on their emotional wellbeing. 
 Other participants spoke about the shock of unexpectedly receiving a diagnosis. Anne 
described her experience of seeing the cancerous tumour on the screen and being informed 
that she had NMIBC while she was on the table undergoing her diagnostic procedure. 
 
‘it was a (doctor) and I was looking at the camera and (the doctor) was able to- and 
next thing (the doctor) came up beside me, (the doctor) was holding my hand and like 
I was “Oh Jesus, what’s wrong here?”. So then (the doctor) said, yes there are 
cancerous cells- cancerous growth there… [] Yes, I could. Yeah, I could. So, I didn’t 
expect that.’ (Anne) 
 
Anne later reported that although she didn’t expect the diagnosis, she accepted that 
she needed to be told. Anne shifted quickly from her emotional expression back to the 
practicalities and timeline of the treatment. Her minimisation of her emotional response is 
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emphasised by her laughter. This gives a sense that Anne is somewhat disconnected from the 
emotional aspects of cancer and the way in which she made sense of the NMIBC was 
grounded in the medical aspects.  
 
‘Yeah, which I didn’t mind to be honest with you. .. Do you know? I think it’s better to 
be… to be told outright, but you know, naturally enough there was a tear but look, 
you get over that. (Laughs) So they brought me in very quickly then after that to 
remove them.’ (Anne) 
 
 In another account, Ellen reported a ten-month history of experiencing the symptoms 
of NMIBC before attending the GP with her complaints. Ellen’s account of receiving her 
diagnosis captured her feelings of shock and surprise as she hadn’t considered the possibility 
of cancer. Her experience of symptoms over a long time as well as undergoing diagnostic 
tests was incongruent with her failure to consider the possibility of cancer. This 
conceptualised her disconnection from the identity of being a ‘cancer patient’. 
 
‘And (the doctor) said, “You have a tumour and it’s cancer and we must have it out”. 
Well, I sat down and all I kept saying was, “I’m after getting an awful…”. Genuinely 
I said, “I’m after getting an awful land”. It was the furthest thing I thought of.’ 
(Ellen) 
 
 For all participants, the diagnosis was central to making sense of their experience of 
NMIBC. While participants integrated the idea of cancer into their understanding of their 
physical health, many participants remained emotionally disconnected from their experience.  
 
4.8.2: NMIBC as a Physical Entity 
NMIBC was conceptualised as a physical entity. In an effort to make sense of the 
disease, participants focused on its physical implications, with less consideration of the 
psychological consequences. When asked about a possible cause of NMIBC, Pat’s remarks 
demonstrated a lack of reflection. Pat’s detachment from a potential cause is underpinned by 
his perception that it is unimportant to making sense of his diagnosis.  
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Em… That’s a question now that I couldn’t answer because, to be quite honest with 
you, I don’t know. [] I don’t know… Eh… They just came on it when they were doing 
tests, you know… I… (Pat) 
 
 When asked about his current view of his health, Pat communicated that he hoped that 
there was ‘nothing wrong’, signifying that he considered his illness in literal terms. More 
specifically, his perception of NMIBC was unequivocal, it was either cured or not cured. 
Similarly, Daniel’s extract captured the relationship between his detachment from the label of 
NMIBC and the process by which it manifests in the body. Multiple meanings can be drawn 
from the extracts, particularly that both participants’ view NMIBC in plain terms. NMIBC is 
either physically present or absent. Pat’s use of the word ‘they’re’ with respect to cure further 
conjured a sense of personal disconnection from his experience of treating the cancer. 
 
Em… Well, you know… Eh, at the present moment, I’m hoping there’s nothing wrong. 
[] That they’re after em… curing it, [] you know? (Pat) 
 
No. I don’t think so. [] Em… I sort of don’t em… look at is as cancer because it was 
cut out. It was grand for a couple of months and… [] Do you know? (Daniel) 
 
 While some participants spoke about the psychological aspects of their experience, 
ultimately a ‘medical model’ of understanding the illness was most prevalent. In order to 
make sense of NMIBC, participants communicated about their experience in categorical 
terms concerning the medical aspects of their disease. For example, Kate, who had 
experienced a number of NMIBC recurrences, made sense of her illness by considering the 
physical implications. 
 
I’ve no pain or anything at the moment, nothing like that. [] I drink n- I love my 
water. But I have to be careful then now, if I’m going out then, [] I would because I 
know myself, I would be running to the loo, you know? (Kate) 
 
 Kate later qualified her understanding of NMIBC as a physical entity by outlining its 
lack of emotional impact on her. Kate’s reference of her previous experience of cancer is 
striking because it illustrated a picture of a woman who has experienced a long history of 
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cancer. Like other participants, her emotional disconnection further highlighted her 
detachment from the psychological aspect of the disease.  
  
No, I never worried or thought about it. [].. As I say, I don’t, I don’t wake up in the 
morning and say “Oh my God, I have bladder cancer or I had (another type of 
cancer)”. No, I don’t really, I don’t. (Kate) 
 
Robert articulated the personal meaning of his experience as a challenge overcome. 
His quote comprehensively captures the complex and dynamic process of making sense of his 
experience. His emotional response is intimately linked with presence of cancer. His use of 
the word ‘extremely’ is dichotomised later by the iteration that NMIBC is unbothersome to 
him. This is critical to understanding that his interpretation of cancer is embedded in the 
temporal nature of the illness. This is highlighted by his dismissal of his emotional response 
once the cancer is no longer present.  
 
Em, it means it’s something that I got through. [] And that was it. At the time I was 
extremely worried, as one would be. [] But em … No. No, no, no. Em… Maybe I’m 
different. It doesn’t bother me in the slightest, being honest with you. [] And at the 
time, it did bother me at the time, of course it did but when I got through it, I said 
“Right that’s it, well done”. (Robert) 
 
 Similar to Pat, the temporal constructs of the illness were crucial to his sense of 
identity. Robert shifted his view depending on visceral presence of the disease. His use of the 
word ‘it’ gives a real sense of disconnection from the disease and that it is in the past. 
Consideration is given to the possibility of recurrence, however, because NMIBC is not 
currently present, it is not tied to his present identity. 
 
No. And I don’t- The-the thing is I had it. I don’t think I have it. [] You know what I 
mean. [] But I do feel it will come back somewhere. (Robert) 
 
 Making sense of NMIBC was closely linked to the ‘here and now’ physical and 
temporal presence of the disease. Essentially, NMIBC was experienced as a physical 
problem. Emotional implications were similarly tied to only the bounds of the treatment or 
detached from personal meaning altogether. Because participants understood their illness 
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within a traditional medical model, it is posited that participants may not have had complete 
insight into their disease and it’s holistic influence on their life. 
 
4.9: Theme 2: The Dynamic Nature of Illness Perceptions  
 Participants spoke about how their personal experiences, prior histories of cancer and 
other health problems impacted on their illness identity. Interpretive analysis further 
encapsulated how the relationship between the patient and doctor served as a basis for the 
way in which control of NMIBC was perceived and understood. 
 
 4.9.1: Illness Identity 
 Patients’ previous personal experiences influenced their identity as a NMIBC patient. 
The majority of participants had numerous family and personal histories of cancer and other 
health problems that shaped the way in which they experienced NMIBC. Daniel’s experience 
of his daughter as a health care professional shaped his view that NMIBC was less serious 
than other health problems. Daniel communicated a sense of NMIBC as benign. This was 
strengthened by his experience of his siblings passing away from other cancers. The extract 
encapsulated the idea that Daniel associated the strength of the physical implications of the 
disease with its severity and thus he did not closely identify with the label of a ‘cancer 
patient’. 
 
Well… The thing is, my daughter had said to me like bladder cancer is one of those 
that’s not as bad as the others, do you know what I mean, once you get it on time. [] 
So, I mean I feel good enough about that like. I mean, like I told you, I’ve sisters who 
died over (description of family experience of other cancers) Cancer like that’s a lot 
worse than the bladder cancer anyway, that’s what I’m saying to you like. (Daniel) 
 
Similarly, Anne described a very extensive history of death in her family as a result of 
cancer as well as her own previous experience of another type of cancer. She drew meaning 
about her identity as a ‘cancer patient’ by contrasting it with her brother’s current experience. 
Her pejorative use of language with respect to her brother’s health and benign use of 
language about her own experience illustrated a real sense of downward social comparison. 
The image of Anne minimising her own experience is striking and illustrated a sense of 




I’ve a brother who’s going through (cancer) at the moment so I’m a very minor case. 
(description of brother’s experience of cancer) … So he’s one of the unlucky ones 
(Anne)  
 
 The way in which participants perceived their health after treatment was a key 
comparison for appraising the label of NMIBC. For example, later on Anne indicated that her 
treatment had few physical implications, in contrast to her brother’s experience of cancer. 
Fewer physical implications had ramifications for her illness identity. Similar to Daniel, this 
quote captured the process of becoming further detached from the characteristics of a ‘cancer 
patient’ by considering her past and current experiences of cancer. 
 
No, no, no, it doesn’t, thank God. I’m still able to go and do everything I want to do. 
(Anne) 
 
 In another example, Kate described her inner conflict with ascertaining the reason for 
her pain prior to her diagnosis of NMIBC, due to also having been diagnosed with another 
chronic health condition. Experience of pain was intimately linked with the chronic health 
condition and not NMIBC. 
 
I was lucky that I did go to the doctor because I… [] I had that pain [] but see I get 
pain with my (chronic health condition) (Kate). 
 
Kate later captured her perception that pain is crucial to her identity as a NMIBC 
patient. The idea of participants experiencing milder symptoms of NMIBC, in the context of 
other current illnesses or a family history of cancer, was critical to having a pervasive sense 
of NMIBC as a more benevolent illness. 
 
And I’ve no pain. I suppose, it’d be different now. Or even if I was going to the 
bathroom now or something and I was sore or burning or… There’s none of that. I 
have no pain. [] I have no pain, [] definitely not. (Kate) 
 
 Physical health ramifications were intimately linked with Kate’s experience of her co-
occurring chronic illness. This quote implicitly indicated that Kate experienced her NMBIC 
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as more benign when compared to her experience of her other illness, with which she more 
closely identified . 
 
I’m limited a little bit, you know. I get tired now [] basically. That’s the only thing 
that do get to me, as you’re talking there now. The fatigue. [] But that- I would put 
that down to the (other chronic health condition) . (Kate) 
 
The impact of participants’ histories of cancer and illness on the way in which they 
identified with NMIBC was striking. Patients tried to integrate their understanding of the 
disease into their lives and this was influenced by their personal experiences and their 
constructed narratives about the severity and impact of NMIBC on their lives. It appeared 
that participants remained at a distance from the label of NMIBC and that it was not 
integrated into their illness perceptions. 
 
Reflective Box: 
As a reflective scientist practitioner undertaking qualitative research, I had a number of 
considerations that required an additional layer of reflection. I had to be mindful of the 
doctor-patient relationship, particularly that the participants are in dependent relationships 
with their doctors. Encouragement from my supervisors to carefully consider these issues 
was helpful in managing the chosen quotes and removing secondary identifiers. 
Additionally, for duty of care, anonymity was extended to both healthcare staff, 
participants and participants’ significant others. 
 
4.9.2: Control 
Perceived roles of the patient and doctor were implicit. Participants understood 
medical staff to have control of their illness and its treatment. The following extract 
encapsulated the idea of perceived roles and responsibilities. The dynamics between patient 
and doctor are very powerful. Control of the illness was firmly placed in the hands of the 
doctor.  
 
‘I come in every six weeks after the laser, so that they can have a look. I come in 
every three months so they can have a look. I’m not medically equipped.’ (James) 
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Placing trust and confidence in the doctor was pivotal to participants’ experience of 
their illness. The power of the perceived expertise of the doctor was intimately associated 
with unyielding trust in the doctor. The strength of the trust in the skill of the doctor often 
mitigated need for a close interpersonal relationship. Trust reflected the way that participants 
perceived that their illness was being managed and accounted for enhanced feelings of 
security. 
  
“I trust (the doctor) emphatically,…. (The doctor) wouldn’t be on my dinner table 
now for a pleasant chat [] but outside of that, who cares? (Robert) 
 
 While some participants required only trust in the skill of the doctor to place control 
in their hands, others required a partnership. Ellen communicated a reliance on her doctor’s 
ability to provide reassurance and comfort her. This acted as a catalyst for the strength of her 
trust in the doctor and ultimately feelings of safety about her treatment. There is a striking 
image of the doctor as a supportive ally, despite Ellen’s dependence on medical expertise. 
 
And, now I had a general anaesthetic for the removal of the regrowth and I’m telling 
you something, [] it was… You wouldn’t have known I’d anything done. [] But (the 
doctor) explains everything and (the doctor) was able to… (the doctor) reassures. 
Like I left there now, not… Really and truly if in the new year regrowth, you’re going 
to say, “Oh no, this thing is back”, but (the doctor) just reassured me. (The doctor) 
said, “No, we’re going to just get rid of that, now there’s nothing to worry about”. 
And (the doctor) kept saying that, [] (The doctor) must have said that about three 
times, [] and I believed (the doctor). [] You know, I genuinely believed (the doctor). 
(Ellen) 
 
 Doctors’ ability to provide information and advice about NMIBC was considered 
integral to the partnership and building of trust. Pat discussed a conversation that he had with 
his doctor about the possibility of having his bladder removed. He experienced the 
communication between the doctor and patient to be empowering, although there is a real 
sense of the doctor having control. The power of the relationship underpinned a pervasive 




And (the doctor is) a (person)  you can talk to and [] explain things to you, and [] tell 
ya the best thing to do. And maybe, em… When I didn’t get the bladder eh, removed, 
eh… (the doctor) put me… (The doctor) said, “I’ll have three tests to do on ya [] and 
if we pass them tests, we’ll talk about it”, and I was called back and I was saying that 
I hope I would pass them. (The doctor) said, “We didn’t find it fit to take out the 
bladder, [] or to talk to you about it”. And em… (the doctor) didn’t tell me what I 
failed in or anything but em… anyhow, (the doctor) knew I wouldn’t do it.  (Pat) 
 
A small number of participants experienced conflict and/or poor communication in 
the doctor-patient relationship which led to trust in the relationship diminishing.  
 
I wanted to know exactly what size [] the growth was inside. [] And the… The person 
coming on couldn’t tell me. [] And I said, “Could you find out for me?”, so they went 
away and came back, “Nobody knows what size, but we know it was em… It was less 
than a centimetre”. [] “Yes, but one second”, I said, [] “I want to know how fast that 
growth was”. [] I think it was the second time that happened because I knew the first 
growth, I think was on three millimetres. [] And he said it was less than a centimetre. 
But how much less than a centimetre was it, I said. [] (They) couldn’t tell me. (Peter) 
 
Like I just... went up to a ward and I was saying, “Why am I here?”, like, I actually 
wasn’t told that [] we’d have to do a procedure on… [] like on the bladder, you know, 
which... (George) 
 
The first example highlighted the value that Peter placed on the doctor-patient 
relationship, particularly the ability of the doctor to provide information. Peter’s perceived 
inability of the doctor to provide information resulted in feelings of tension and frustration. 
Similarly, George, already a patient due to a history of another type of cancer, spoke about 
his confusion of being diagnosed with NMIBC due to his perceived lack of doctor-patient 
communication. The quote captured an image of frustration and an exacerbation of feelings 
of uncertainty about his medical treatment.   
In another example, Joe described a long road to diagnosis and treatment due to 
perceived delays with the referral and perceived failings in communication in the health 
service. Joe experienced his relationship with his doctor to lack effective communication. 
The extract highlighted the tensions evident in the relationship and diminished trust. Joe’s 
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experience had negative implications for his sense of control over his health which led him to 
advocate for himself by booking a private appointment with his doctor. Multiple meanings 
can be drawn from this quote, particularly that Joe’s mistrust created a perception of 
increased risk with his treatment. 
 
I was getting quite annoyed because I was seeing less and less of (Doctor’s Name) on 
these visits, [] seriously less. And so, I made a private appointment [] to see (Doctor’s 
Name), [] and I duly got it and I went, and I said, “What’s going on? I don’t know 
what’s going on. One minute I’m allergic to BCG and then I’m… you know…”. And 
then (the doctor) explained the situation, in his eyes, that em… the first two courses, 
which had gone successfully, em… were the most important and-and basically watch 
it. (Joe) 
 
 Joe qualified this later by highlighting his fear that the cancer would spread. Joe’s 
view of his illness can be conceptualised by considering the strength of his relationship with 
his doctor. His experience of a disconnected doctor-patient relationship, resulted in mistrust 
and ultimately greater fear about his health. 
 
Em… In the earlier days, they would ensure that you got the results verbally from a 
doctor of the CT scan, [] so put your mind at rest that it wasn’t spreading [] 
anywhere else in your body. [] That’s disappeared. (Joe) 
 
 The analysis captured the processes by which illness perceptions of control are 
created and factors such as interpersonal dynamics that impact on their development. Positive 
perceptions of the doctor-patient relationship resulted in better perceptions of NMIBC. 
Perceived failures in the system, such as a lack of doctor-patient information led to a more 
pejorative view of NMIBC.  
 
4.10: Theme 3: Coping  
 The theme of coping embraced patients narratives of finding ways to manage their 
illness and difficult emotions. The three inter-related subordinate themes of isolation, 




 Participants were very aware of the reciprocal interactions between their emotional 
wellbeing and their families wellbeing. In an attempt not to burden family members, many 
participants avoided telling them about their diagnosis.  
 
I just wouldn’t bother you know, worrying them, like you know basically, like you 
know yourself, there’s… [] you’d always have…. [] extra worry you know. 
(Laughing) (George) 
 
George had not informed his adult children about his illness and although his wife 
was aware of his NMIBC, they had not communicated about it. The extract illustrated that he 
did not want to place the emotional burden of worry on his family. 
 
I just say ya know, what’s the point, ya know kind of ya know… [] Ya know 
conversations that aren’t (Laughs) positive, ya know how it is. (George) 
 
Here, there is an implicit indication that negative experiences are not spoken about in 
the home. The quote encapsulated the image that when presented with an aversive 
experience, George restricted himself from speaking about it, in an effort to cope. Therefore, 
George is in a position of managing the emotional experience of his illness in isolation. 
Similarly, Anne had not told her adult children about her diagnosis, symbolising her 
desire to protect her family. Her minimisation of her own needs justified her decision not to 
inform them which ultimately left her in a position of isolation.  
 
They don’t need to be worrying about me. They’ve enough to be doing with in their 
own lives. (Anne) 
 
Later Anne reflected on the impact of isolation. 
 
what’s the point in worrying them but… I suppose if I had done, they’d be more 
aware of me. Like they all get on with their- they’re all adults, [] they all get on with 
their grandkids and everything else. They all get on with their own lives and I don’t 
impose in their lives as such. [] We’ve a good relationship, don’t get me wrong, but 
maybe if I had told them, they might have been a bit more about the Mammy. Do ya 
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know but sure I mean, [] for God sake, sure they’ve enough to be doing [] with their 
own lives, do ya know? (Anne) 
 
The extract is fraught with ambivalence. It captured the internal conflict of not 
wanting to be burdensome to others. However, there was also a sense of loneliness connected 
to not having the support of her children, and this appeared to lead to the recognition that her 
emotional needs were not met. Anne’s subsequent minimisation of her needs supported her 
ability to remain stoic. 
 Isolation was conceptualised as a helpful self-reliant coping strategy. There is a 
remarkable image that Robert and Pat could direct their emotional wellbeing in a way that 
gave them a sense of personal control and it ultimately created a sense of empowerment. 
 
Yeah. I- I kept it to myself and that was that. [] You know, [] but, em… When I was 
told [] that I had cancer on the bladder, em… What I said was, “Is it curable?”. They 
said yes, “Okay…”, I said, “I’ll fight that”. [] And it never worried me about having 
cancer on the bladder. (Pat) 
 
I don’t really tell them [] unless they really want to know. [] I don’t go round with the 
kind of I’m a survivor badge or em… [] I just get on with it, I think. (Robert) 
 
Interpretative analysis reflected patients’ emotional response to NMIBC in the context 
of their current situation. Some of the responses can be considered as participants protecting 
their family from difficult emotions, resulting in managing their experience of NMIBC in 
isolation. Additionally, for others, the emotional responses of isolation was viewed as an 
adaptive coping strategy.  
 
4.10.2: Cognitive Appraisal  
 Managing cognitive responses was considered an important coping strategy. 
Participants often spoke about the importance of accepting their diagnosis and treatment. 
 




 George communicated a sense that he is at ease with his experience of cancer, 
emphasised by his laughter. He takes the view that negative events, such as NMIBC, in life 
are inevitable and uncontrollable. Externalisation of the problem supported his ability to 
remain resilient.  
 Furthermore, many participants managed their cognitive responses by employing the 
strategy of minimisation, in an effort to cope. 
 
I don’t… I don’t treat it as a problem. I treat it as an issue that’s there, [] move on 
from it. (Peter) 
 
But I said “That’s life”. I mean, life comes at ya. You can decide to lie down and it 
will roll over ya or you can say, “Right” and you don’t… I’m not fighting cancer, I’m 
dealing with tumours and that’s about the size of it and I will deal with them as best I 
can. You can’t fight cancer, [] it’s not something you can take out and batter around 
the place, it happens. (James) 
 
 Here, Peter illustrated deliberate selection of his thoughts about managing his illness. 
Denial that NMIBC is a problem provided self-reassurance and a coping strategy. Similarly, 
James described a subtle shift in his view that he is not ‘fighting’ cancer, he is ‘dealing’ with 
it. Minimisation of the illness evokes the sense that he consciously manipulated his 
cognitions in a way that he found adaptive. 
 Through Daniel’s narrative, it became clear that he carefully considered his cognitive 
response to attending his routine cystoscopy appointments. 
 
I wouldn’t say it’s anxious or anything like this, it’s just…[] A bit of a hinderance. A 
bit of a nuisance really but it’s fine. They’re all very nice, I mean there’s no problem 
at all. (Daniel) 
 
 Daniel’s quote symbolised his negative view of considering his medical procedures in 
emotional terms. Here, he downplayed the emotional significance of the procedure. His use 
of the phrase ‘a bit’ in his description implied a deliberate choice of cognitions in his 
approach to coping. 
 
4.10.3: Emotion-Focused Coping 
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Many participants reflected on their experience of keeping difficult emotions at bay as 
a way to cope. For Kate, there was a sense that sitting with difficult emotions was 
maladaptive. Avoidance of confronting difficult emotions such as fear and anxiety was 
experienced as functional. 
 
I don’t dwell on it really, to be quite honest with ya. And I said it isn’t a conversation 
we have kind of really. (Kate) 
 
 As outlined earlier, Ellen avoided visiting the doctor with her symptoms for 10 
months. This quote comprehensively captured the complex and dynamic process of coping. 
In an effort to cope, Ellen disconnected herself from the reality of her situation through 
avoidance. She had observed her father’s painful death from cancer and this difficult memory 
was a persistent presence lurking in the background of her mind. The ramifications of this 
influenced her avoidant behaviour. 
 
but I think it was my own fault. I’m the one with my head in the sand, I didn’t want to 
know. [] Now, I do now because I feel so good now. [] I feel… But at the time, I just 
didn’t want to think I was going down the same road as my father. [] You know a 
coward really. (Ellen) 
 
 Ellen later reflected on her ongoing ambivalent relationship with managing her 
emotions. 
 
Like when I talk now even to (Partner’s Name) about it and he says, “You know 
you’re so blasé, whatever”, I’m afraid but I talk to myself then, I’m afraid that it’s 
like the denial of… of when I was… before I was diagnosed. [] Would that be a bit of 
it as well? But then I say, “No, I’m different to what I was…”. No, I’m genuinely… [] 
It’s a- It’s a genuine… genuinely, em… I suppose we all fear but the fear I have is 
suffering because I saw my father suffering. (Ellen) 
 
 The traumatisation that Ellen experienced as a result of her father’s experience is 
striking. The feeling of fear was internalised by Ellen and led to pervasive avoidance. The 
tentativeness of her delivery symbolised her internal battle about the effectiveness of her 
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avoidance in adjusting to her illness. Ellen’s self-reassurance is best understood in the context 
of the dynamic nature of coping.  
 In another extract, Joe reflected on his ability manage difficult emotions in response 
to NMIBC. 
 
It’s a very hard place to be. [] Now my personality, thank God, is I keep doing things 
that I can. Em… I go sailing... I’ve just done a little tour of the (location) with a 
caravan, [] em… just to keep myself occupied. [] Yeah. [] Em… And the 
psychological side of it hits me most at the end of the day. [] Bedtime or just before 
bedtime, then I go into deep thought about what’s going on.  (Joe) 
 
 Multiple meanings can be drawn from this extract. Distraction by engaging in 
enjoyable activities was considered an adaptive way of managing overwhelming and difficult 
emotions. The quote nicely captured Joe’s attempts to distance himself from his emotions 
before succumbing to their ruminative advances at night-time.  
 Later, Joe expressed the full extent of his ruminative thoughts. Joe’s earlier attempts 
to avoid the discomfort of difficult emotions was considered by him to be functional. 
However, it did not lead to associated distress diminishing and Joe was left to consider his 
illness in pejorative terms, which ultimately increased his experience of overwhelming 
emotions. 
 
As soon as somebody says cancer to you, [] you’re counting the days in your mind, 
you know. [] How long is it going to be and how long have I got left to live, et. 
Cetera, et. Cetera. (Joe) 
 
Joe’s fear of NMIBC as a mortal disease was intrinsically linked to his emotional 
wellbeing and had implications for feelings of disempowerment. It is possible that his 
feelings of a significant threat to his physical health resulted in mirrored feelings of threats to 
his emotional well-being. 
 
Reflective Box: 
Participants deliberate selection of and insight into their chosen coping strategies was 
striking. I observed that participants often decided not to speak to others about their illness, 
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in an effort to reduce burden on their families. Furthermore, great efforts to manage 
thoughts and difficult emotions were evident.  
In order to make meaning of the data, I considered the cultural contexts from which the 
patients existed. Age and location were just some of the factors that I considered when 
attempting to understand the experiences of the participants. I found myself frequently 
reading and re-reading Smith and colleagues (2009), engaging in reflection and using 
supervision to make sense of the worlds of the participants. 
 
 4.11: Chapter Summary  
The quantitative and qualitative results have been explained and detailed. The 
























Chapter 5. Discussion 
5.1: Introduction 
This is one of the first studies to date to use the SRM to examine illness perceptions, 
coping and psychological distress in NMIBC patients on surveillance. In addition, it is the 
first study to include a qualitative element to examine the full SRM in the context of NMIBC.  
 The discussion chapter provides a summary and critical discussion of the quantitative 
and qualitative main findings, in the context of the current literature. Following this, an 
integration of the results are delineated. Methodological considerations regarding both the 
strengths and limitations of the current study are outlined, while consideration is given to a 
critical reflection of the research process. Implications for clinical practice and future 
research are stated as well as an overall conclusion. 
 
5.2: Reviewing the Research Questions 
 Due to the identified gaps in the literature in terms of understanding patients with 
NMIBC on surveillance, perceptions and experiences, it seemed appropriate to adopt an 
exploratory approach. The SRM offers a cohesive and empirically validated psychological 
model of understanding the manner in which individuals perceive and cope with illness 
(Moss-Morris et al., 2002). Furthermore, research has substantiated that the model has been 
effective at explaining psychological wellbeing outcomes in patients with cancer (Richardson 
et al., 2015). Despite the influence of illness perceptions on coping and its impact on the 
psychological outcomes of cancer, the role of illness perceptions pertaining to NMIBC 
patients has received very little attention. From the small amount of research carried out in 
relation to this population, limitations were identified. For example, research was often 
conducted without a theoretical basis and frequently incorporated patients at all stages of BC 
(Pham et al., 2019). This study combined the strengths of both quantitative and qualitative 
research designs to achieve a more comprehensive understanding of the illness perceptions 
and experiences of the participants.  
 The quantitative component sought to examine illness perceptions in patients with 
NMIBC on surveillance and explore the extent to which illness perceptions and coping 
explained psychological distress. The qualitative phase aimed to explore the lived 
experiences of patients on surveillance specificlly in terms of their illness perceptions, coping  
and psychological wellbeing. By giving a voice to the patients, a current limitation of the 
existing research, it was possible to go beyond the quantitative measures in order to achieve 
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greater insight into the lived experience of the participants. All findings are discussed in the 
context of the broader, existing literature.  
 
5.3: Key Quantitative Findings 
 The following section provides an account of the key quantitative findings, in the 
context of the literature. 
 
5.3.1: The Prevalence of Psychological Distress 
 The results found that 15.8% and 38.3% of patients were experiencing clinically 
significant symptoms of depression and anxiety respectively. This finding is comparable to 
the levels of distress reported in other studies investigating cancer including: breast cancer 
(Gibbons, Groarke, & Sweeney, 2016), oesophageal cancer (Dempster et al., 2012) and head 
and neck cancer (Hodges & Humphries, 2009). Additionally, it fits with findings by Dauphin 
and colleagues (2019) which reported that 40% of cancer patients over the age of 70 and 17% 
of patients aged between 50 and 69 reported psychological distress. Despite the lack of a 
large scale review examining psychological distress among patients with NMIBC, Pham et 
al. (2019) found that psychological distress is associated with a diagnosis of BC. Findings in 
this study, help to understand psychological wellbeing among patients with NMIBC on 
surveillance.  
 
5.3.2: Illness Perceptions 
 Analysis was conducted in order to examine illness perceptions among patients with 
NMIBC on surveillance. Participants perceived the Timeline of their illness to be long-
lasting/chronic, to have a considerable emotional impact, but relatively low Consequences on 
their lives. Patients reported a good understanding of NMIBC and had high perceptions of 
Controllability of the disease by medical treatment. However, perceptions of Personal 
Control over their illness was lower than that of Treatment Control. In this study, patients did 
not closely identify with NMIBC. Findings here are consistent with Tan and colleagues 
(2020), with the exception that participants in the current study considered NMIBC to have a 
more significant emotional impact on their lives. However, in the case of (Tan et al., 2020), 
patients’ had just received a diagnosis of NMIBC, so more negative Emotional 
Representations in this study may reflect that patients had more time to experience the 
psychological aspects of the disease. This is the only study, that the researcher is aware of, 
that has evaluated illness perceptions of patients’ on surveillance who have received 
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treatment for NMIBC, and serves to illustrate a picture of the way in which patients 
perceived their illness. 
 
5.3.3: Demographic, Clinical and Psychological Factors Associated with Anxiety 
and Depression  
 One of the aims of this study was to determine the demographic, clinical and 
psychological factors associated with psychological distress. Contrary to findings in the 
literature (e.g., Yessil-Cinkir & Elboga, 2020) demographic and clinical variables comprising 
of gender, age, years since diagnosis, type of treatment, marital status, employment status, 
history of psychiatric problems and tobacco consumption were not found to be associated 
with psychological distress.  
 The current study aimed to investigate the relationships between illness perceptions, 
coping and psychological distress. As predicted, it was found that more negative perceptions 
of Consequences, Timeline, Identity, Concern and Emotional Representations about NMIBC 
were positively correlated with greater psychological distress. This is consistent with 
previous research (e.g., Richardson et al., 2015). Interestingly, more positive perceptions of 
Illness Coherence and Control was not negatively associated with psychological distress, a 
finding less easy to explain (Hopman & Rijken, 2015).  
 Patients with more negative illness perceptions reported greater use of avoidant-based 
coping strategies, consistent with the existing literature (Richardson et al., 2015). It has been 
demonstrated that approach coping styles are beneficial while avoidant/emotion-focused 
coping styles are maladaptive with respect to psychological wellbeing (e.g., Hudson, Bundy, 
Coventry, & Dickens, 2014). Interestingly, while patients who used more avoidant coping 
strategies experienced greater psychological distress as predicted, it was found that patients 
who engaged in more active/approach coping strategies did not report reduced psychological 
distress. This finding was contrary to the hypothesis. However, similar findings have been 
reported in the literature, for example with gynaecological cancer patients (Gould, Brown, & 
Bramwell, 2010). These findings lend support to the SRM for the influence of negative 
perceptions of illness on avoidant coping strategies which ultimately impact psychological 
wellbeing outcomes. 
 
5.3.4: Predictive Model of Depression and Anxiety  
 In the final model illness perceptions accounted for approximately 16.1% of the 
overall variance in depression scores, while coping strategies accounted for 4.4% of the 
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variance. Only perceptions of Emotional Representations and avoidant coping strategies 
predicted depression. For anxiety scores, in the final model, illness perceptions accounted for 
approximately 49.2% of the overall variance, while coping strategies accounted for 5.5% of 
the variance. Perceptions of Timeline and Emotional Representations as well as avoidant 
coping strategies predicted anxiety.  
 The findings are in line with existing research. Emotional Representations have 
consistently been demonstrated to be the strongest illness perceptions predictor of 
psychological outcomes in patients with cancer (Dempster et al., 2015; Richardson et al., 
2015). Similarly more negative Emotional Representations are the strongest predictor of 
avoidant coping strategies (Richardson et al., 2015). With respect to the predictive power of 
Timeline in relation to anxiety scores, given that older age is a risk factor for NMIBC and has 
high recurrence rates, it is possible that patients may be anxious about the permanency of 
their condition and are ultimately concerned about its impact on their lifespan.   
The finding that only a small number of illness perceptions predicted psychological 
distress was somewhat unexpected. Previous research has demonstrated that a number of 
illness perceptions predicted psychological distress in NMIBC patients (Zhang et al., 2019). 
However, in a meta-analytic review of 254 studies conducted by Hagger and colleagues 
(2017), results found that Emotional Representations had the largest effect size in its ability 
to consistently predict both avoidant coping strategies and psychological distress in a broad 
number of chronic health conditions. Furthermore, perceptions of Consequences, Identity and 
Emotional Representations were considered to be more threatening at the time of diagnosis 
than post-treatment (Hagger et al., 2017). In the current study, all patients had received 
treatment and were on surveillance. This may account for the finding that only perceptions of 
Emotional Representations and Timeline predicted psychological distress. Another 
explanation for the findings is that patients in this study had sufficient time to habituate to the 
consequences and symptoms of NMBIC and adhere to the treatment protocols. Use of 
avoidant coping strategies is a common approach to managing threatening cognitions. It is 
well established that avoidant coping is an important factor in the development and 
maintenance of psychological distress (e.g., Trew, 2011). Although patients may have 
learned to avoid discomforting thoughts about the consequences and symptoms of their 
illness, use of avoidant/emotion-focused coping strategies are ultimately ineffective and thus 
long term psychological distress persisted.  
 While the conclusion that levels of anxiety and depression in patients are influenced 
by the distress stemming from experience of NMIBC is hardly surprising, these results 
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additionally contribute to the existing knowledge. This is the first study that has supported the 
theoretical implication that illness perceptions and coping influence a significant proportion 
of the explained variance in psychological distress in patients with NMIBC on surveillance. 
Participants who consider their illness timeline in more chronic terms and as being more 
emotionally impactful on their lives were more likely to rely on avoidant coping strategies 
that ultimately lead to deleterious psychological outcomes. This research also extends 
previous research by providing partial support for the SRM in predicting psychological 
distress. More specifically, the results tentatively suggest that maladaptive coping is more 
integral to psychological wellbeing than adaptive coping strategies. In this sample, use of 
approach coping strategies were not negatively associated with psychological distress, as 
predicted. Therefore, supporting patients with negative illness perceptions and helping to 
reduce use of avoidant based coping strategies may be key to the improvement of 
psychological outcomes. Given the exploratory and tentative nature of the quantitative 
findings, the qualitative component additionally serves as a way to understand better the 
processes at work within the SRM. 
 
5.4: Key Qualitative findings 
 The following section provides an account of the key qualitative findings. As 
presented in the results, this study generated three main themes which encompassed: Making 
Sense of NMIBC, The Dynamic Nature of Illness Perceptions and Coping.  
In this section the quantitative and qualitative findings are integrated. More 
specifically, the qualitative results are outlined in a manner that attempts to better understand 
the quantitative findings. Smith et al. (2009) acknowledged the power of combining IPA with 
quantitative designs. IPA supports a nuanced understanding of participants who can become 
lost in statistical analysis. More specifically, IPA draws on relational and cultural processes 
to give a contextual explanation for quantitative findings (Smith et al., 2009). Therefore, the 
discussion is delineated in the context of the broader literature. The SRM can provide a 
framework for helping patients create a coherent understanding of NMIBC. The qualitative 
findings underline the complexity of illness perceptions in the context of NMIBC. Thus, 
interpretation is nuanced in order to give a full account of the lived experience of patients 
with NMIBC on surveillance.  
 
5.4.1: Theme 1: Making Sense of NMIBC 
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The SRM as a theoretical framework was considered a useful guide to understanding 
the lived experiences of the participants, specifically because it acknowledges the role of 
illness stimuli including symptoms, personal experiences, information received by health-
care staff and the role of diagnosis in the development of illness perceptions (Moss-Morris et 
al., 2002). While the current study reflected these theoretical constructs, it garnered a greater 
insight into the processes by which NMIBC was understood and accepted. All participants 
explored their own personal narrative of their diagnosis, and how those experiences shaped 
their perspectives. Diagnosis was most frequently discussed in literal terms with little 
consideration of the emotional aspects of the experience. Participant narratives highlighted 
discussion about the physical implications of NMIBC and ongoing disconnection from the 
emotional aspects of the disease. It was clear that participants may have lacked full insight 
into some facets of the disease. Consideration is given to the potential reasons why 
participants presented in this manner. 
The small number of studies that have qualitatively explored cancer patients illness 
perceptions, in the context of the SRM, have demonstrated mixed results whereby adult 
patients diagnosed with leukaemia integrated the physical and psychological aspects of their 
experience of diagnosis into their perceptions of the disease (Koenigsmann et al., 2006) and 
the experience of being diagnosed with gynaecological cancer was understood in more 
practical and temporal terms (Phillips et al., 2017). Therefore, divergences in findings across 
the literature require close consideration of the cultural context of this study. It could be 
suggested that, in this instance, dealing with the practicalities of diagnosis may have been 
considered overwhelming and thus dealing with the psychological aspects of diagnosis may 
have appeared an insurmountable additional task. It is clear that participants in the current 
study, described experiences of diagnosis in diminutive terms and presented themselves as 
‘normal’ and in some cases ‘healthy’. This is in keeping with the research that suggests that 
men who have experienced a urological cancer make considerable efforts to protect their 
social status in order to maintain their identity with respect to their sense of health and 
masculinity (Neris, Leite, Nascimento, García-Vivar, & Zago, 2020). Specific to Ireland, 
Geary and Murphy (2015) argued that Irish men are socialised to conceal their emotional and 
physical vulnerabilities which impacts negatively on their emotional wellbeing. Thus, by 
considering the cultural contextualisation of the group of participants, it may, in part, explain 
their narratives.  
 Deliberate attempts to supress difficult emotional experiences in a manner that 
negatively impacts on the self is termed experiential avoidance (Bond et al., 2011). There is a 
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body of literature that has described some of the conceptual overlaps between experiential 
avoidance and the masculinity paradigm. Masculinity is a fluid and socially constructed 
concept whereby the thoughts, feelings and behaviours of men are viewed in an idealistic 
manner (Johnston & Morrison, 2007). Both experiential avoidance and masculinity involve 
the attempted control of emotions which can ultimately give rise to deleterious mental health 
outcomes (Spendelow & Joubert, 2018). Given that many men, in this study, did not 
explicitly speak about the psychological aspects regarding their understanding of their 
diagnosis, it is possible that the thoughts and feelings that they had in relation to these events 
were directed internally. This may have functioned as a way to protect their social status. 
Similar findings have been demonstrated for female patients. For example, White, Hunter, 
and Holttum (2007) found that women who had experienced a myocardial infarction (heart 
attack) tended to minimise the impact of their symptoms prior to diagnosis in an effort to 
maintain their perceived role as being normal, in control and strong. With this in mind, it is 
hypothesised that older Irish people, both male and female, may have been socialised to hide 
their perceived weaknesses (Lane & Smith, 2018). This explanation may partially account for 
the finding that patients lacked complete insight into the emotional aspects of their diagnosis. 
It further provides additional information to the way in which the participants sought to 
understand their diagnosis and treatment in the context of their cultural beliefs and values.  
 The quantitative part of the study included illness stimuli variables such as type of 
treatment and number of years since diagnosis in order to understand their impact on illness 
perceptions. While the quantitative findings provided a framework for understanding 
experiences of NMIBC, the qualitative component has served as a way to go beyond the 
model to better understand the way in which thoughts, feelings and behaviour shape beliefs, 
coping and psychological outcomes.  
 
5.4.2: Theme 2: The Dynamic Nature of Illness Perceptions 
A narrative shared amongst participants was the ways in which their personal 
histories and experiences impacted on their illness identity. Illness identity is a core construct 
of the SRM and the role of personal experiences on the development and influence of illness 
perceptions of identity nicely fits within the structure of the model (Hagger et al., 2017). 
Evidence of this was observed when participants reflected on their personal and/or significant 
other’s illness history. These experiences played a critical role in keeping their illness identity 
as a NMIBC patient at an emotional distance. A commonality of experience for patients 
related to their difficulty incorporating experience of NMIBC into a coherent personal illness 
 77 
identity, despite having experienced diagnosis, treatment (and in some cases multiple 
treatments) and surveillance procedures. This is antithetical to the development of a holistic 
understanding of disease and has been mirrored in the literature, particularly when patients 
have few symptoms and low levels of pain (Phillips et al., 2017; Tan et al., 2020). Reduced 
pain, receiving treatment and being on surveillance influenced participants’ illness identity, 
meaning that they internalised beliefs about the disease as being relatively benign. 
Comparative findings have been illustrated in the literature where patients reported poor 
understanding of many aspects of their illness and had unrealistically low-risk perceptions 
about their disease (e.g., Besser, Anderson, & Weinman, 2012). While patients understood 
the chronicity of their disease and it’s seriousness for others, participants struggled to 
integrate it into their beliefs about its personal significance. This ambivalence may reflect 
avoidant coping. While, it is clear that the SRM provides the bedrock to understanding 
perceptions of individuals with NMIBC on surveillance, the qualitative component of this 
piece of research provides a more nuanced and full account of the lived experience of 
patients.  
Within this theme, participants’ narratives conveyed a collective importance of 
perceiving the doctor to be in control of their treatment. Trust in the health system in relation 
to medical treatment appeared to trigger feelings of reassurance. Participants spoke about the 
expertise of healthcare professionals, while a clear understanding and separation of doctor 
and patient roles were implicit and underpinned the narratives of this theme. When patients 
perceived their treatment to be under control, they were better able to mitigate their own 
stress, particularly when healthcare staff communicated appropriately with them about their 
treatment. This is in line with the literature (e.g., Koenigsmann et al., 2006). While on the one 
hand, trust in the doctor’s ability to manage treatment can be considered adaptive, it can also 
be discordant because it can encompass diminished feelings of personal control and 
responsibility. The quantitative results found that most participants, in this study, had strong 
perceptions of Treatment Control and reduced perceptions of Personal Control. From a 
qualitative perspective, it is possible that the level of responsibility placed on the doctor, to 
manage NMIBC, can be conceptualised as a form of rationalisation or denial. It is 
hypothesised that when the specifics of information about the diagnosis and treatment of 
NMIBC becomes overwhelming, patients disconnect from it, in an effort to manage. This 
finding is supported in the literature (Matchwick, Domone, Leroi, & Simpson, 2014). 
Although empirical research has demonstrated that stronger perceptions of Treatment Control 
are associated with better psychological outcomes (Zhang et al., 2019), the impact of trust on 
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the role of denial appears to additionally be important in determining adjustment. In this 
study, the quantitative findings found that perceptions of Control were not significantly 
associated with psychological distress. However, illness perceptions are mutable over time 
(Hulgaard, Rask, Risør, & Dehlholm, 2020). Adding to the current literature, the examination 
of patients on surveillance helps to improve our understanding about patients perceptions of 
control and their influence on illness beliefs and subsequent outcomes. Essentially, patients 
may believe that they are responding pragmatically to their illness by placing control in the 
hands of the doctor which can simultaneously heighten passive coping strategies. 
For some patients, the role of information provision from their doctor was crucial to 
trust in the relationship and the development of positive illness perceptions. The importance 
of the provision of clear information for elderly cancer patients has been well established in 
the literature (e.g., van Ee et al., 2019). Of interest, within the SRM qualitative literature, 
perceived inadequacies of information received from health care professionals has been 
found to adversely impact on patients view of their illness and their emotional wellbeing 
(e.g., Nicholls, Glover, & Pistrang, 2009). Receiving timely, appropriate and clear 
information about NMIBC aids emotional self-regulation and nicely fits with the constructs 
of the SRM. Again, these findings add to and go beyond the quantitative results to provide a 
richer account of illness perceptions. 
 
5.4.3: Theme 3: Coping 
Illness perceptions and coping responses to NMIBC from the quantitative component 
of the research were understood according to the SRM theory. In particular, patients with 
more negative perceptions about the chronicity and emotional impact of NMIBC were more 
likely to engage in avoidant coping strategies that were associated with adverse consequences 
for their psychological wellbeing. The qualitative findings further informs the quantitative 
results. Three coping strategy themes emerged during the qualitative phase comprising of 
isolation, emotion-focused coping and cognitive appraisal. Isolation and emotion focused 
coping are avoidant coping strategies. Avoidant coping was related to poorer psychological 
adjustment, as measured by the HADS, and this was additionally illustrated in the qualitative 
results. For example, individuals who isolated themselves from receiving social support in 
relation to their illness, resulted in the prevention of their emotional needs being met and 
were more likely to be distressed. Others presented isolation as functional, specifically that it 
enhanced feelings of empowerment and control. In this context, the presentation of isolation 
as being adaptive can be considered in terms of denial, an avoidant coping strategy, which 
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over time leads to unfavourable psychological outcomes. Furthermore, emotion-focused 
coping was qualitatively conceptualised as functional. However, it was clear that the use of 
distraction, rumination and disconnection from the illness experience leads to heightened 
emotional avoidance and ultimately greater emotional distress.  
Cognitive appraisal is considered adaptive (e.g., Stanton, Wiley, Krull, Crespi, & 
Weihs, 2018). While the quantitative findings indicated that approach coping was not 
associated with reduced psychological distress, the qualitative results provide a more nuanced 
explanation. Of interest, participants spoke about employing the use of cognitive 
restructuring techniques in an attempt to cope and further stated that it resulted in enhanced 
resilience and overall improved psychological adjustment. At a superficial level of 
interpretation, cognitive restructuring can be considered beneficial. However, at a more 
complex level of interpretation, it is hypothesised that these efforts can mirror cognitive 
strategies such as minimisation, which are maladaptive. Key to many participants’ narratives 
was disconnection from NMIBC and minimisation of its impact would fit with this. This type 
of analysis has not been previously identified in the literature, and provides additional insight 
into the way in which coping strategies are chosen and their effectiveness. Cognitive 
appraisal was considered functional by participants but in some cases it was maladaptive. 
Identification of maladaptive coping could be helpful in creating malleable targets for 
psychological intervention. 
 Findings from this study extend the literature through additional insight in to the way 
in which coping strategies are chosen and evaluated. Similar to previous research, 
participants are active in choosing coping strategies (e.g., Phillips, Elander, & Montague, 
2014). Coping processes are conceptualised dynamically in the SRM, and these findings 
reflect that NMIBC patients are active and not passive in their selection. Patients are also 
active in attempting to manage psychological responses. Mirroring the current findings, many 
cancer patients tend to rely on passive and avoidant coping strategies (Richardson et al., 
2017). This is an interesting finding because it highlights the preferred coping strategies of 
cancer patients and potential avenues for psychological intervention. Of interest, there is little 
empirical evidence that supports the endorsement of active/approach coping strategies in 
people with more chronic/long term illnesses (Dempster et al., 2015; Vriezekolk, van 
Lankveld, Geenen, & van den Ende, 2011). Therefore, supporting the reduction of avoidance 
coping may be more beneficial. 
 Moving to the broader literature, the psychological experience of BC has been 
qualitatively explored, without the underpinning of a theoretical model. Typical emotional 
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responses to BC were strong in intensity and comprised of fear, shock, upset and devastation 
(Edmondson et al., 2017). While the review did not specifically consider coping among 
NMIBC patients, it highlighted common concerns for BC patients including sexual and body 
image concerns. The present findings were discordant with Edmondson and colleagues 
(2017) given that these concerns were less prevalent in the current sample. Again, this may 
reflect the cultural socialisation of the participant population. To provide a possible 
explanation, it is hypothesised that there is significant emphasis and value attached to 
stoicism in Irish culture (Lane & Smith, 2018; Richardson, 2012; Sadler, 2019). Considering 
that participants tended to view their illness within the confines of the traditional medical 
model, this may have played a part in rejection of the emotional aspects of NMIBC. Thus, 
complaints about body image issues and sexual functioning may have been considered 
superfluous to physical health and were not openly discussed. Additionally, within a 
biopsychosocial framework of understanding illness, participants may not have linked all of 
the physical, social and emotional consequences of NMIBC to their own experience, 
reflecting possible reluctance to disclose. 
 
5.5: Methodological Considerations 
 This study encompassed both strengths and limitations. The methodological 
considerations for this study are delineated. 
 
 5.5.1: Limitations  
This study was a cross-sectional design and as a result conclusions about the causality 
between the reported relationships are limited. With this in mind, findings from this study are 
suggestive that illness perceptions and coping affect psychological distress during 
surveillance.  
The avoidant coping subscale on the Brief COPE yielded a reliability of α = .55. This 
conflicts with previous research which has demonstrated acceptable reliability for the 
subscale (e.g., Cartwright et al., 2008). The avoidant coping subscale comprised of a variety 
of heterogeneous coping strategies (e.g., substance abuse and denial). The low reliability 
score can be explained by the variety of heterogeneous avoidant coping strategies that may 
not have been not applicable to all participants. 
Given that research has demonstrated that personal experiences influence illness 
perceptions (Ashley, Marti, Jones, Velikova, & Wright, 2015), it was an oversight not to 
include a question about prior history of cancer in the quantitative phase. If it had been 
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included, this variable could have been controlled for during analysis. Comparatively, 
considering that the study incorporated a mixed methods design, the impact of these 
experiences were uncovered and elucidated during qualitative analysis. 
Participants were recruited to the quantitative phase of the study at their out-patient 
appointment clinic. Any concerns or anxieties about the appointment itself may have affected 
the way in which participants responded to the self-report measures. Completion of the 
questionnaire booklets may have been more appropriate at a different time/location. 
Recruitment of cancer patients is challenging and thus a sensible approach was taken. A 
number of measures were selected to reduce distress; firstly participation was entirely 
voluntary, the measures were brief and took a short amount of time to complete and finally 
there was an option to complete the questionnaires at home and return via a pre-stamped and 
addressed envelope. 
 While the use of IPA is considered a strength of the study, any limitations are well 
documented. Use of an audit trail and reflective journal provides clarity, transparency and the 
opportunity to reflect on the researchers personal experiences and biases in order to reduce 
their effect.  
 Interviewing participants at only one time point during their experience of 
surveillance, can be considered a relative limitation. Conducting a number of interviews with 
each participant may have strengthened the researcher-participant relationship ultimately 
leading to the collection of richer data. This was not possible given the time constraints of the 
study, and therefore the researcher attempted to mitigate this by relying on general clinical 
skills, particularly empathy. 
 While it is not the goal of IPA to extrapolate to the wider population, the 
characteristics of this particular sample merit discussion. Participants self-selected to take 
part in the interviews and this might reflect a group of people who are more verbose and 
willing to speak openly about their experiences. Each individuals story had a great degree of 
complexity that was entrenched in their social and cultural life experiences. While 
participants shared many common experiences, they also had different backgrounds and life 
experiences and therefore cannot necessarily be considered a completely homogenous 
sample. With this in mind, it may only be possible to consider these findings in the context of 
the particular cultural and geographical region. Exclusion criteria in this study did not 
preclude patients with a prior history of cancer or the presence of current additional illnesses 
to participate. This limitation may have added to the heterogeneity of the sample. On the 
other hand, old age and smoking are risk factors for BC, populations that are inherently more 
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likely to have experienced both previous and current health problems. Therefore, it is argued 
that a more open inclusion criteria is, in fact, more reflective of a BC population. 
 
5.5.2: Strengths  
This study encompassed a number of significant strengths. This study was the first to 
address illness perceptions, coping and psychological distress among patients with NMIBC. 
Generally, it contributed to the SRM illness perceptions literature. The inclusion of the 
qualitative component offered important insights into the lived experiences of the patients 
that served to expand the existing literature.   
 An important strength of the research design was the utilisation of a mixed methods 
approach because it addressed gaps in the literature and significantly contributed to the 
existing literature. Integration of a quantitative and qualitative research design allowed for a 
greater exploration and understanding of the SRM in the context of NMIBC patients on 
surveillance. Findings from the qualitative component served as a way to explain the 
quantitative results. It is clear, that the use of a mixed methods research design achieved 
greater insight than either method could have accomplished alone. 
 As acknowledged, the use of IPA was a significant asset to this study for a number of 
reasons. Firstly, this approach facilitated the collection of data with considerable depth which 
helped the double hermeneutic process. More specifically, use of the semi-structured 
interview allowed participants to reflect on and interpret their personal experiences which 
then created a space for the researcher to engage in these processes ultimately benefiting the 
hermeneutic circle. The way in which research trustworthiness and credibility was ensured 
was previously outlined. Therefore, interpretive analysis can be considered reliable, although 
it is always possible that different conclusions can be drawn from a qualitative data set. 
 Finally, the researcher was not a staff member in the hospital and had no direct link to 
the medical team. Explicit communication of this to patients created a sense of safety and 
reduced the possibility of the impact of power differences, leading to the accumulation of 
richer data. It enabled the researcher to better understand what it is like to experience NMIBC 
and its treatment. 
 
5.6: Implications for Clinical Practice 
 A number of implications for clinical practice emerged from this piece of research. 
Experience of diagnosis was found to be a key theme in the formation of illness perceptions. 
Due to its importance, there is a clear need for health care staff to use best practice guidelines 
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when delivering a cancer diagnosis to the patient. Research has established that patients with 
a malignancy typically wish to be completely informed about their illness, particularly so that 
they can take part in decisions about their treatment (Mori et al., 2019). In a recent review of 
the literature, Taher (2019) put forward a number of steps that support good practice in 
delivering a diagnosis; communicating the information in an appropriate manner, supporting 
the patient and engaging in a shared doctor-patient partnership regarding the treatment plan. 
Social and cultural issues should be respected and the delivery of the diagnosis to elderly 
patients should be carried out in a manner compatible with the patients ability to comprehend 
any information being shared (Fitch, McAndrew, & Harth, 2015). The review emphasised the 
importance of doctor-patient communication whereby; health care professionals are sensitive 
to the patients emotional responses, give sufficient time to deliver the diagnosis in private, 
are explicit and use easy to understand language that is jargon-free; repeat information as 
necessary; allow time to answer questions; arrange further appointments as needed and 
finally deliver the information with compassion and empathy (Taher, 2019). Additionally, 
these steps support the amelioration of power differences in the doctor-patient relationship. It 
is recommended that clinicians are trained appropriately, using best practice guidelines. 
 The identification of the factors that influence illness perceptions and coping 
strategies which result in deleterious psychological health outcomes are crucial because they 
can be utilised to develop appropriate psychological interventions. Research has 
demonstrated that targeted interventions can improve illness perceptions. For example, 
Pourfallahi, Gholami, Tarrahi, Toulabi, and Moghadam (2019) found that a 10-week 
supportive information intervention improved cancer patients illness perceptions. It is clear 
that patients value the doctor-patient relationship. Positive relationships that are 
compassionate, helpful and genuine are absolutely key and may be fundamental to the 
malleability of illness perceptions. 
 A number of research studies have been conducted to examine the effectiveness of 
psychological interventions aiming to reduce psychological distress, in the context of the 
SRM. Interventions are more beneficial to patients with cancer when they target negative 
illness perceptions and avoidant coping (O'Brien & Moorey, 2010). Stress management 
interventions that incorporate the use of cognitive behavioural therapy strategies have proved 
successful in urological cancer populations (e.g., Trager et al., 2013). Findings from the 
current study identified that a proportion of patients with NMIBC on surveillance exhibited 
negative illness perceptions, engaged in avoidant coping and experienced psychological 
distress. Therefore, in order to support this group of patients, negative illness perceptions and 
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avoidant coping should be targeted. Interventions that incorporate knowledge from the SRM 
are more likely to be effective at reducing psychological distress (e.g., Dempster et al., 
2011a). 
 Findings from the qualitative research illuminated the idea that NMIBC is a complex 
experience. Many participants did not share their thoughts, feelings and emotions with their 
families. Cultural aspects of the sample’s experience such as stoicism have been delineated. 
Therefore, it is clear that health care professionals working with patients are in a key position 
to develop positive relationships. In order to develop meaningful relationships, patients 
should be respected. Offering individualised one-to-one psychological interventions may 
support patients who are reluctant to communicate with their families or to groups because 
they are confidential and offer privacy.  
  
5.7: Implications for Future Research 
The majority of research conducted on illness perceptions is cross-sectional. 
Considering the limitations of cross-sectional research designs, it has been suggested that 
prospective longitudinal research study designs would enhance understanding of illness 
perceptions among patients with NMIBC over a period of time (e.g., Cartwright et al., 2009). 
It would be useful to determine whether perceptions of NMIBC change from diagnosis, 
treatment, surveillance, recurrence of BC to recovery. Alternatively, it has been suggested 
from longitudinal research that illness perceptions are unlikely to change over time 
(Dempster et al., 2015) although this is counter to the fluid nature of the SRM. A prospective 
longitudinal design would help to tease apart possible fluctuations.  
The main outcome measure in this study comprised of psychological distress. Future 
studies should include a range of outcome measures including physical health outcomes, 
social and role functioning and quality of life. This would help to examine whether or not 
illness perceptions and coping are important predictors of various outcomes. In this regard, 
the literature base could be extended and the experience of patients with NMIBC could be 
further understood. 
Carrying out further qualitative research could aim to clarify and develop results. It 
would be useful to interview patients following diagnosis and at various timepoints 
throughout treatment, surveillance and  recovery in an attempt to map the lived experience of 
illness perceptions and adjustment over time.  
Finally it would be interesting to explore caregivers and partners lived experience of 
supporting a patient with NMIBC. This would be a particularly interesting area of research, 
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where the research question could focus on illness perceptions, coping and psychological 
distress. From the limited available research, there is evidence to suggest that caregivers and 
partners with more negative illness perceptions are more vulnerable to deleterious 
psychological outcomes including post-traumatic stress disorder (PTSD) (Richardson, 
Morton, & Broadbent, 2016), anxiety and depression (Dempster et al., 2011b). 
 
5.8: Critical Reflection 
 The researcher acknowledges the importance of reflecting on her positioning, pre-
conceptions and values in relation to this study. As with any qualitative piece of research, 
these processes can impact analysis.  
 Regarding my positioning within the research; the author is a white, Irish, 29-year-old 
woman from a middle-class background. As a clinical psychologist trainee, I had, thus far, 
limited experience of supporting cancer patients experiencing psychological distress. My 
personal interest in this piece of research originated from my background in health 
psychology and natural empathy for patients with cancer. Like most Irish people, I have seen 
the effects of cancer in my extended family and community. Information disseminated in the 
media has only underlined the pervasiveness of the problem. It was these experience that 
shaped my passion for understanding their experiences. 
 While I had a certain amount of knowledge about urological cancers, this was my first 
experience of talking to individuals with BC. I was continually struck by the degree of 
complexity to every participants’ experience. Everything from discussion about physical 
symptoms to health care encounters and interpersonal experiences, was fascinating and 
somewhat overwhelming. Reflective journaling allowed me to understand my naivety that, of 
course, patients bring with them not just their illness but their life experiences. Cancer does 
not exist in a vacuum. Making use of supervision and ongoing reflection really aided my 
ability to be mindful of my thoughts, feelings and emotions in relation to the interviews. In 
that way, I found that I could remain open-minded to hearing the narratives of the 
participants while keeping an objective outlook. Using simple grounding exercises, based on 
mindfulness principles, before and after interviews also added to my ability to keep an 
objective lens. 
 I also considered pre-existing norms that I held about cancer patients. The participants 
were significantly older than me and because I have been fortunate enough to have never 
personally encountered cancer, I was concerned that I would have difficulty relating to 
patients. I found that my previously held beliefs were challenged. What was striking to me 
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was discovering that patients were simultaneously vulnerable and resilient and ultimately 
human. Drawing from this understanding made connection possible. It was at this point , that 
I finally understood the hermeneutic circle. My ability to form connections with patients 
enhanced their ability to make sense of their story as they told it and my ability to interpret it. 
This was crucial to the research trustworthiness and credibility processes. 
 As a novice IPA researcher, I found the data analysis phase particularly challenging. 
It brought up many frustrations for me, principally in my attempts to reflect the narratives of 
the participants accurately. The task was a time consuming and arduous process. The 
responsibility that I felt to create a picture of the complexity of individual lived experience 
was both demanding and stimulating. It was during moments of reflection that I truly 
appreciated the daunting task of living with cancer. It helped reveal to me my own sense of 
intimidation through undertaking the formidable task of IPA research. While my own 
experience was in no way parallel to the participants, it gave me some awareness of how 
threats are navigated in order to remain resilient. This illustrated to me the flexibility and 
deftness participants managed to achieve when drawing upon internal support mechanisms to 
cope with their illness. 
 
5.9: Conclusion  
 This study investigated the lived experiences of patients with NMIBC on surveillance 
with regard to their illness perceptions, coping and psychological distress. The SRM theory 
was selected due to its existing empirical evidence base. Significant gaps in the literature, 
with respect to this population, became apparent in a review of the literature.  
 This study was one of the first to provide an account of illness perceptions, coping 
and psychological outcomes in patients with NMIBC on surveillance. Findings showed that 
 15.8% and 38.3% of patients were experiencing clinically significant symptoms of 
depression and anxiety respectively. Regarding illness perceptions, participants perceived the 
Timeline of their illness to be long-lasting/chronic, to have a considerable emotional impact, 
have relatively low Consequences on their lives and they did not have a strong Identity 
towards the illness. Patients reported a good understanding of NMIBC and had high 
perceptions of Controllability of the disease by medical treatment. Stronger Emotional 
Representations and use of avoidant coping strategies predicted depression. While, stronger 
perceptions of Timeline and Emotional Representations as well as avoidant coping predicted 
anxiety. It was concluded that an interrelationship existed between these variables which had 
a role in explaining the variance in psychological distress. 
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 The qualitative phase of the research illustrated the complexity of the illness. The 
identification of the three super-ordinate themes, (1) Making Sense of NMIBC, (2) The 
Dynamic Nature of Illness Perceptions and (3) Coping attempted to synthesise elements of 
lived experience of the disease. For people with NMIBC on surveillance, the development of 
illness perceptions was related to the broader social and cultural context of their lives. 
Participants tended to view their illness in equivocal terms rather than holistically. Previous 
life experiences and health system encounters shaped participant’s illness identity and 
perceptions of the way in which NMIBC was being controlled. Avoidant coping was 
prevalent and the way in which strategies were chosen and evaluated are clearly delineated in 
the discussion section.  
 The SRM was ultimately considered a useful framework for understanding how 
individuals perceived and coped with NMIBC. Explanations were provided regarding the 
way in which these processes were negotiated. Finally, consideration was given to the 
strengths and limitations of the research as well as clinical and research implications.  
 It was a privilege to meet with participants and hear their stories. With this in mind, it 
is hoped that this research adds to the existing literature and supports the use of best practice  
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Semi-Structured Interview Schedule  
Setting: Interviews will take place in room (removed for anonymity)  
Duration: 60 minutes per interview approximately 
 
Stage 1 – General introduction  
- Remind participant of stage 1 of the research.  
- Remind of the purpose of the study. Written consent form reviewed. Verbal consent 
requested. 
- Provide a verbal reminder of (a) the interview is being recorded, and (b) participation 
consent can be withdrawn at any time. 
- An explanation of confidentiality will be provided. As part of this, all participant will be 
informed that the data will be transcribed and made anonymous. The research and 
supervisors will be the only people who can access the data. 
Remind participants that participation is entirely voluntary. A decision to withdraw will not 
have any impact on current or future care. 
- Provide a description of the interview process – for example, its exploratory nature and 
there are no correct or incorrect answers. Remind participants that I am interested in hearing 
about their opinions and experiences. Confidentiality will be repeated here, ensuring 
participants that any data collected will be anonymised, transcribed and only the researcher 
and supervisors will read the transcripts.  
- Answer any additional queries. 
 
Stage 2 – Introduction  
Hello, thanks for meeting me today to take part in the research. My name is Ruth and I am a 
psychologist in clinical training. We spoke on the phone. I’m doing some research here with 
the urology team at X Hospital to understand more about people’s experiences with early 
stage bladder cancer. 
The purpose of the research is to understand more about peoples’ lived experiences of having 
this type of cancer, what you think, feel, believe and how you feel it affects your life. I will ask 
you a number of questions but please feel free to talk as openly as possible about your 
experiences.  
 
You can stop the interview at any point and only answer questions you are comfortable with 
answering. The interview should last approximately 60 minutes and you can let me know if 
you require a break.  
Is there anything you’d like to ask me before we start? 
 
Stage 3 – Interview  
General prompts:  
• Can you tell me a bit more about that? • Earlier you mentioned (....) what was that like for 
you? 
 
A lot of people with early stage bladder cancer have different opinions and experiences. I am 
interested to know about your experience and your beliefs about it. 
 
1. Introductory Question:  
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I’d like to ask about your experience of early stage bladder cancer. Can you tell me your 
story, from the beginning, of what has happened to you—what made you think something 
was wrong, what you did then, what happened when you first saw a doctor, and so on up to 
now. 
 
2. Cause: A lot of people have their own ideas about what caused their illness.  
-What ideas do you have about the cause of yours? How do you think it started? 
Follow up questions to ascertain the origin of ideas: e.g. Is that what your doctor told you? 
Are there other people in your family with a similar illness? Do you know anyone else who 
has a similar illness? 
 
3. Identity:  
- Many people have their own ideas about what might be wrong with them; in your opinion, 
what did you think is wrong with you? 
- How do you describe your illness to other people?  
- What does the experience of having early stage bladder cancer mean to you? 
- Do you have any other experience with this type of cancer (e.g., family history or other 
people you know? If so, has this affected your experience of the illness? If so, how?  
 
4. Emotional Representations:  
- To what extent do you feel having had early stage bladder cancer impacted how you 
generally feel in yourself moodwise? 
- Can you tell me about any negative feelings (e.g., fear, anxiety)?  
- Or any positive feelings (e.g., relief)? Does it bother you? 
 
5. Consequences:  
- What is the impact of it on your life?  How did it change your life and what you do?  
- What are the most difficult aspects of your cancer?  
- Have there been any good aspects of your cancer? What are they? 
- Compared with other illnesses, how serious do you think your illness is? (if necessary: 
compared, for example, with heart disease). 
- Having had treatment for your cancer, how do you see the future in 6 months/1 year/5 
years/10 years and so on? Do you have fears/expectations/hopes? 
- What are your views on: Planning for the future, relationships, work and recurrence of early 
stage bladder cancer? 
 
6. Timeline:  
- How did you feel when you were diagnosed? How did you feel when you were getting 
treatment? What about now – has it changed over time?  
- How do you think you will be in 6 months/1 year? Do you think that it will change over 
time? If so, how? 
 
7. Control/cure: Some people find ways to manage their illness;  
- How much control do you think you have over your symptoms/illness? 
- What things did you do to deal with your symptoms? What worked? What didn’t work? 
- What do you think can be done to make you better? 




Has anything helped you cope with your experience of cancer? (e.g., family, friends, partner, 
faith, hobbies, etc). 
How did they help?  
 
9. Anything else you’d like to talk about that I haven’t asked? 
 
 
Stage 4 –Debrief  
- Thank the participants for participating in the research.  
- Answer and additional questions or queries. 
- A verbal debrief will be provided. 
- If a participant has experienced distress, they will be reminded of the supports available. 
Participants can be referred to the clinical health psychology department in X Hospital for 
further support if needed. The researcher can discuss any issues of concern with Dr. Helen 
Richards, Principal Clinical Psychologist, attached to the Urology Unit (co-investigator of the 
research). Any support provided will be on a confidential basis. 



















































Time as a valuable resource. 
















Need for reassurance. 
 
 
Her experiences in the past 













Participant Ellen 16  
* Dialogue in brackets 
represents the other 
speaker interjecting 




Participant Ellen: And all I 
was worried about was 
em… Oh I hate now wasting 
time because they were 
there, I mean the whole day 
they went through an awful 
lot of trouble putting me 
through this machine and all 
of this. I was like Jesus I’m 
wasting their time and now 
there’s somebody genuinely 
now God love that’s ill 
needs to be looked after. 
[Yes] So I don’t really. I 
actually don’t talk about it. 
[Okay] Not even to 
(partner). [Okay] I don’t 
even… and he said, “Will 
you be talking?”. I said, “I 
don’t know but I hope it’ll 
help somebody”. [Okay] I 
thought it was only just kind 
of like that it could help 
somebody, [Okay] you 
know reassure them [Yes] 
that I’m… I’m living proof- 
genuinely that oh my God. 
[That you’ve come out the 
other side of it] Like cancer 
years ago, you’d kind of writ 
yourself off. [Okay, yeah] It 
doesn’t seem to affect me at 
all.  
 
Interviewer Ruth: Okay. 
So, in the past maybe, I 
know you had mentioned 
like in your own family 
years ago, maybe it 









‘All I was worried about’ – 
emphasis on not wasting 




At this point, Ellen still did 
not consider the possibility 
that she had a ‘genuine’ 











Reassurance as a way to 
cope. Consideration of 
others and not the self. 
 
 
Perception of cancer – 
Ellen’s past history 
indicated that cancer was a 
terminal illness? 
 
Is Ellen avoiding the 



















Traumatic nature of father’s 
death? 
Time (it happened quickly) 










Outward appearance as an 





















Importance of early 
detection of cancer. 
 
Avoidance/Denial – coping 
strategy? 
 
about. [Never] Well maybe 
that’s changed a little bit 
now? 
 
Participant Ellen: Thanks 
be to God! [Yes] Because 
I’m alive today because… 
Like, I would genuinely say 
if my father had of been 
caught in time, he would 
have got a good few years. 
[Yes] I mean, he was dead at 
six weeks. So, he was told… 
Well it was (the doctor) here 
in the (hospital). He’s 
probably dead himself now 
or well retired… No, he’s 
probably dead cos he was an 
old man. [Okay] He em… 
He just said it was totally 
inoperable. It was gone all 
over him; it had spread 
everywhere. [Okay] But I 
knew by looking at him 
before he came in, I knew. 
[Yes] I knew by looking. 
Like I didn’t see any of that 
in me.  
 
Interviewer Ruth: Okay, 
you didn’t have that look in 
your complexion. 
 
Participant Ellen: No.  
 
Interviewer Ruth: But I 
wonder then Ellen, like 
having this early stage 
bladder cancer, did it mean 
anything to you in 
particular? Did it have a 
meaning personally? 
 
Participant Ellen: The 
mean- No. What I mean is 
the meaning it had to me 
was, I caught it in time 
because I nearly very 
stupidly ignored it, only for 









father’s death as preventable 
 






‘it had spread everywhere’- 
image of cancer as 
malignant and unstoppable 
 
Perception of cancer as 
being related to the where 
the person looks ill 
externally. Her father looked 
ill and died. Ellen does not 
see this in herself and 
perceived herself as healthy? 






Definitive. Ellen perceives 









Ellen discusses the 
importance of catching 
cancer early. 
Avoidance? Not going to the 
doctor with symptoms until 
















Is Ellen self-critical about 
her own response? 
Recognition of need for 
medical help. 




to the doctor about the 
bleeding. [Yes] That the 
slightest little thing now for 
anyone, the slightest little… 
Go to your doctor, [Yes] talk 
about it, [Okay] because it 
was pure fluke I mean if I 
hadn’t mentioned that. 
 
Interviewer Ruth: Okay. 
Maybe, maybe it would 
have been further down the 
line before you contacted… 
 
Participant Ellen: And 
they’re on the radio, they’re 
on the television, they’re 
everywhere advertising talk 
about you- Any symptoms, 
any change, anything- you 
go to your doctor.  
 
Negative self-talk – 
referring to herself as 












Reiteration about the 
importance of going to the 
doctor. 
 
Something about Ellen not 










































Appendix H: Extracts from reflective diary/memos 
 
30/05/2019  
Supervision with Supervisor and field supervisor in host organisation to discuss the research. 
We had a long discussion about the research question and the theoretical model being used in 
the research. Participant recruitment and the timeframe of data collection was also spoken 
about. It gave me the opportunity to reflect on some of the challenges of the research, 
particularly the limited amount of time available to complete the research. A Ghant chart may 
be helpful to manage my time.  
23/07/2019  
I began the process of contacting potential participants about taking part in the interviews. It 
was helpful to consider how to communicate the voluntary nature of the study while being 
very clear about my role. There appears to be a lot of interest in the project which I found 
very invigorating.  
08/08/2019 
Today I conducted my first interview. It was both challenging and enjoyable. I was nervous 
at the beginning but found I settled into it after a few minutes. The participant was very 
articulate and open. At different times, I had to draw upon my clinical skills to listen to the 
participant’s narrative and keep track of the interview topics. I am looking forward to 
listening back to the interview in order to consider if I could have done anything differently 
to improve its depth.  
23/10/2019  
Great interview today. The participant appeared to enjoy the experience and spoke openly 
and freely about the topic. It allowed for great depth of understanding her experience. It 
allowed me to appreciate the benefit of the semi-structured interview in its flexibility to 
facilitate deep engagement with the topic.  
13/11/2016  
I attended an IPA workshop today. I found it a really useful space to reflect on my 
transcriptions and analysis so far. However, I’m finding the transcriptions very time 
consuming and frustrating. Going back to the principles of IPA was a useful grounding 
exercise. 
14/02/2020  
Really struggling with data analysis. As a novice IPA researcher, I have found abstraction of 
the themes a significant challenge. Attending supervision today was very helpful. I think that 
I am too close to the data and gaining another perspective aided the reflection process. It 
helped me to realise that by doubting myself, I had become overly descriptive rather than 
interpretive. I need to trust in the data – back to the drawing board.  
 121 
31/03/2020  
Feedback on my written drafts has been very helpful. To write a synthesised account of my 
results and discuss them in the context of the literature has been both challenging and 
intellectually stimulating. I need to go back over my work, be succinct and make a good 













































Appendix I: Stages of Bladder Cancer 
 
 
Stages of Bladder Cancer 
________________________________________________________________________ 
Stage Ta:  This is when the growth occurs on the lining of the bladder and has not 
invaded any layer of the bladder. 
Stage Tis:  Also known as Carcinoma in situ (CIS). It is a flat tumour that has grown 
within the inner lining of the bladder. 
Stage T1:  T1 occurs when the tumour has entered the second layer of the bladder but has 
not invaded the muscle. 
Stage T2a:  The tumour has invaded the superficial muscle layer. 
Stage T2b:  The tumour has entered the deep muscle layer. 
Stage T3a:  The tumour has invaded the muscle and grown into fat tissue located near the 
bladder. 
Stage T3b:  This stage is similar to T3a however the tumour has also grown into the 
peritoneum layer of the bladder. 
Stage T4a:  The tumour has spread to nearby structures/organs such as the prostate, uterus 
or vagina. 
Stage T4b: The tumour has grown into the pelvis or abdomen and may have spread to 
nearby lymph nodes. 
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